东东南亚的个人主页 - 老虎社区

东东南亚

东东南亚

说就说点有含金量的话！

IP属地：北京

38关注

34粉丝

0主题

0勋章

11-22 06:15

[强][强][强]

11-16

加油[强][强][强] 坐在风口上哪怕是稍微晚点的风口一样可以起飞！美股确实是科学的股市，是真的能让人民赚钱的股市。

2023-09-11

那是真不挣钱吗？懂的都知道都是财务作假，钱都进了个人腰包。

李佳琦有多能“挣”？个人年收入打败93%的A股公司

2023-09-01

什么情况

提醒：香港交易所取消今日全天的交易，因八号风球仍然生效

2023-08-26

不要被金钱冲昏头脑，专注创新和发展，人工智能领域前景广阔，人类的进步不应止于此。

意外，英伟达宣布250亿美元回购传递了什么信号？

2023-08-24

$英伟达(NVDA)$ 重要提示！英伟达现在可以卖房买了！ $特斯拉(TSLA)$ $微软(MSFT)$

2023-08-24

$英伟达(NVDA)$ 英伟达INVDA.0/2024财年第二季度营收135.1亿美元，上年同期67亿美元，，市场预期112.24亿美元。

2023-04-18

$CME比特币主连 2304(BTCmain)$ $Riot Blockchain, Inc.(RIOT)$ $Coinbase Global, Inc.(COIN)$ 大饼近期趋势震荡下行，以下市场消息均不利于加密货币近期走势。 1.国际清算银行行长，利率可能需要保持在更高水平，而且持续的时间可能比此前预期的要长。 2.【苹果与高盛合作的Apple Card高收益储蓄账户今日上线】金十数据4月17日讯，苹果公司官网4月17日宣布，与高盛合作的Apple Card高收益储蓄账户于今日上线，目前提供4.15%的年利率。一旦用户通过Apple Card设置了储蓄账户，来自Apple Card的每日奖励金会自动存入该账户。用户还可以通过一个关联的银行账户将资金存入储蓄账户，并且可以随时将资金转出到关联的银行账户，过程不收取任何费用。

2021-08-04

扎克排名很重要，希望多发一些

Analysts Estimate Novavax (NVAX) to Report a Decline in Earnings: What to Look Out for

2021-08-04

一切看成果，没有成果的事情都是耍流氓。

3 COVID Stocks That Could Soar Higher

2021-06-17

嗯

7 Best Growth Stocks to Buy in June

2019-12-18

$特斯拉(TSLA)$重要提示$Netflix, Inc.(NFLX)$$苹果(AAPL)$$伯克希尔(BRK.A)$$阿里巴巴(BABA)$$微软(MSFT)$特斯拉目前为历史最高点，潜在突破位置，两种可能一是回调，二是突破新高千亿市值(个人认为千亿可期)，无论从哪里看特斯拉已经是成熟企业，值得千亿市值了。总的来说目前位置是高点，持有有风险也可能有收益。不能否认这个位置肯定有很多人会选择空。现在就看是空头获胜还是多头获胜。但是从技术上来看，今年6月份到目前12月份特斯拉股价的走势及波动判断，本次新高是一定会突破的。更重要的是我认为奈飞现在是行情启动点了，2020年2月份奈飞股价大概率400往上。也就是说我判断奈飞从现在持有到明年2月份大概率事件会有30%左右的收益。

2019-11-27

$特斯拉(TSLA)$大锤貌似砸的是前车门，后车窗玻璃也碎了呀[疑问]

2019-11-23

$特斯拉(TSLA)$发点看法，不知道对不对，第四季度10万多的销售量能达到吗？国内特斯拉听说明年一月份才能交付，是不是今年第四季度表示并不能帮上什么忙吧？那么全面的销售目标我觉得有很大风险是达不到的啊。还是觉得全年目标有点风险。

2019-10-22

$特斯拉(TSLA)$今天我打算说点有价值的话了，特斯拉这个股票现在可以卖房买了！$苹果(AAPL)$$Netflix, Inc.(NFLX)$$伯克希尔(BRK.A)$$中国恒大(03333)$

2019-07-01

$特斯拉(TSLA)$ 230以下今晚买多少都赚钱！千万别错过这波，马上就出Q2创纪录后边最少还有8个点的涨幅，拿稳了最高可能触及280这波

2019-06-26

$西部数据(WDC)$ 今天盘后怎么涨这么多？

2019-03-30

$特斯拉(TSLA)$ 特斯拉国内大家可能都在等国产，所以国内销售现在应该不会太多

2019-03-16

$特斯拉(TSLA)$ 昨晚特斯拉美股大跌榜排名第十，真牛掰

2019-03-15

$特斯拉(TSLA)$ 我还就真杠上了，打死我也不卖，有种你就跌吧

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3479576576056160","uuid":"3479576576056160","gmtCreate":1516483411045,"gmtModify":1516483411045,"name":"东东南亚","pinyin":"ddnydongdongnanya","introduction":"","introductionEn":"","signature":"说就说点有含金量的话！","avatar":"https://static.tigerbbs.com/d8c94e66f07db4943f9b584d30f6937f","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":34,"headSize":38,"tweetSize":43,"questionSize":0,"limitLevel":900,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":14,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-4","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"明星虎友","description":"加入老虎社区2000天","bigImgUrl":"https://static.tigerbbs.com/dddf24b906c7011de2617d4fb3f76987","smallImgUrl":"https://static.tigerbbs.com/53d58ad32c97254c6f74db8b97e6ec49","grayImgUrl":"https://static.tigerbbs.com/6304700d92ad91c7a33e2e92ec32ecc1","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.15","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"228c86a078844d74991fff2b7ab2428d-3","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资合伙人虎","description":"证券账户累计交易金额达到100万美元","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"93.54%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"93.41%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":4,"crmLevelSwitch":0,"location":"北京","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":1,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":373504175784344,"gmtCreate":1732227332476,"gmtModify":1732227334575,"author":{"id":"3479576576056160","authorId":"3479576576056160","name":"东东南亚","avatar":"https://static.tigerbbs.com/d8c94e66f07db4943f9b584d30f6937f","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3479576576056160","authorIdStr":"3479576576056160"},"themes":[],"htmlText":"[强][强][强]","listText":"[强][强][强]","text":"[强][强][强]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/373504175784344","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":371394555068712,"gmtCreate":1731712153785,"gmtModify":1731712156772,"author":{"id":"3479576576056160","authorId":"3479576576056160","name":"东东南亚","avatar":"https://static.tigerbbs.com/d8c94e66f07db4943f9b584d30f6937f","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3479576576056160","authorIdStr":"3479576576056160"},"themes":[],"htmlText":"加油[强][强][强] 坐在风口上哪怕是稍微晚点的风口一样可以起飞！美股确实是科学的股市，是真的能让人民赚钱的股市。","listText":"加油[强][强][强] 坐在风口上哪怕是稍微晚点的风口一样可以起飞！美股确实是科学的股市，是真的能让人民赚钱的股市。","text":"加油[强][强][强] 坐在风口上哪怕是稍微晚点的风口一样可以起飞！美股确实是科学的股市，是真的能让人民赚钱的股市。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/371394555068712","isVote":1,"tweetType":1,"viewCount":108,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":218761652711456,"gmtCreate":1694432587593,"gmtModify":1694432589184,"author":{"id":"3479576576056160","authorId":"3479576576056160","name":"东东南亚","avatar":"https://static.tigerbbs.com/d8c94e66f07db4943f9b584d30f6937f","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3479576576056160","authorIdStr":"3479576576056160"},"themes":[],"htmlText":"那是真不挣钱吗？懂的都知道都是财务作假，钱都进了个人腰包。","listText":"那是真不挣钱吗？懂的都知道都是财务作假，钱都进了个人腰包。","text":"那是真不挣钱吗？懂的都知道都是财务作假，钱都进了个人腰包。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/218761652711456","repostId":"1134923605","repostType":2,"repost":{"id":"1134923605","pubTimestamp":1694428627,"share":"https://www.laohu8.com/m/news/1134923605?lang=&edition=full","pubTime":"2023-09-11 18:37","market":"sh","language":"zh","title":"李佳琦有多能“挣”？个人年收入打败93%的A股公司","url":"https://stock-news.laohu8.com/highlight/detail?id=1134923605","media":"华尔街见闻","summary":"“李佳琦带货怼网友”的话题在网络引起广泛讨论。","content":"<html><head></head><body><p>“李佳琦带货怼网友”的话题在网络引起广泛讨论。</p><p style=\"text-align: start;\">近日，李佳琦在直播活动中介绍79元一支的花西子眉笔时，看到有网友留言说越来越贵了，他反问：“哪里贵了？这么多年都是这个价格，不要睁着眼睛乱说，国货品牌很难的……哪里贵了？”</p><p style=\"text-align: start;\">随后，李佳琦又说：“有的时候找找自己原因，这么多年了工资涨没涨，有没有认真工作？” </p><p style=\"text-align: start;\"><strong>那么李佳琦本人有多能“挣”呢？</strong></p><p style=\"text-align: start;\">有数据显示，在“2021年度中国网络主播年度净收入百强榜”中，李佳琦以年度净收入18.553亿元高居榜首，年收入超过大部分上市公司的业绩。</p><p style=\"text-align: start;\">据上证报记者统计，目前5274家A股上市公司中，2021年归母净利润低于18.553亿元的公司有4897家，占比达93%！<strong>这意味着，李佳琦年净收入超过93%的上市公司净利润！</strong></p></body></html>","source":"live_wallstreetcn","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>李佳琦有多能“挣”？个人年收入打败93%的A股公司</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n李佳琦有多能“挣”？个人年收入打败93%的A股公司\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-09-11 18:37 北京时间&nbsp;&nbsp;&nbsp;<a href=https://wallstreetcn.com/charts/41954742><strong>华尔街见闻</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>“李佳琦带货怼网友”的话题在网络引起广泛讨论。近日，李佳琦在直播活动中介绍79元一支的花西子眉笔时，看到有网友留言说越来越贵了，他反问：“哪里贵了？这么多年都是这个价格，不要睁着眼睛乱说，国货品牌很难的……哪里贵了？”随后，李佳琦又说：“有的时候找找自己原因，这么多年了工资涨没涨，有没有认真工作？” 那么李佳琦本人有多能“挣”呢？有数据显示，在“2021年度中国网络主播年度净收入百强榜”中，...</p>\n\n<a href=\"https://wallstreetcn.com/charts/41954742\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/3cfbab38e9154bc47023225fee260424","relate_stocks":{},"source_url":"https://wallstreetcn.com/charts/41954742","is_english":false,"share_image_url":"https://static.laohu8.com/cc96873d3d23ee6ac10685520df9c100","article_id":"1134923605","content_text":"“李佳琦带货怼网友”的话题在网络引起广泛讨论。近日，李佳琦在直播活动中介绍79元一支的花西子眉笔时，看到有网友留言说越来越贵了，他反问：“哪里贵了？这么多年都是这个价格，不要睁着眼睛乱说，国货品牌很难的……哪里贵了？”随后，李佳琦又说：“有的时候找找自己原因，这么多年了工资涨没涨，有没有认真工作？” 那么李佳琦本人有多能“挣”呢？有数据显示，在“2021年度中国网络主播年度净收入百强榜”中，李佳琦以年度净收入18.553亿元高居榜首，年收入超过大部分上市公司的业绩。据上证报记者统计，目前5274家A股上市公司中，2021年归母净利润低于18.553亿元的公司有4897家，占比达93%！这意味着，李佳琦年净收入超过93%的上市公司净利润！","news_type":1},"isVote":1,"tweetType":1,"viewCount":824,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":215181989482600,"gmtCreate":1693541365936,"gmtModify":1693541367329,"author":{"id":"3479576576056160","authorId":"3479576576056160","name":"东东南亚","avatar":"https://static.tigerbbs.com/d8c94e66f07db4943f9b584d30f6937f","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3479576576056160","authorIdStr":"3479576576056160"},"themes":[],"htmlText":"什么情况","listText":"什么情况","text":"什么情况","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/215181989482600","repostId":"1184540436","repostType":2,"repost":{"id":"1184540436","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1693540132,"share":"https://www.laohu8.com/m/news/1184540436?lang=&edition=full","pubTime":"2023-09-01 11:48","market":"hk","language":"zh","title":"提醒：香港交易所取消今日全天的交易，因八号风球仍然生效","url":"https://stock-news.laohu8.com/highlight/detail?id=1184540436","media":"老虎资讯综合","summary":"9月1日，香港交易所取消今日全天的交易，因八号风球仍然生效。","content":"<html><head></head><body><p>9月1日，香港交易所宣布，由于八号台风信号现正生效，今天（星期五）的证券及衍生产品市场全日暂停交易，包括收市后交易时段。所有证券结算及交收服务今天亦暂停。沪深股通今天亦暂停。</p><p></p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/6af126257307047d8d851c94070759ca\" tg-width=\"1920\" tg-height=\"572\"/></p><p></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>提醒：香港交易所取消今日全天的交易，因八号风球仍然生效</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n提醒：香港交易所取消今日全天的交易，因八号风球仍然生效\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2023-09-01 11:48</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>9月1日，香港交易所宣布，由于八号台风信号现正生效，今天（星期五）的证券及衍生产品市场全日暂停交易，包括收市后交易时段。所有证券结算及交收服务今天亦暂停。沪深股通今天亦暂停。</p><p></p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/6af126257307047d8d851c94070759ca\" tg-width=\"1920\" tg-height=\"572\"/></p><p></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/09caddfc0c2d2ea28b3db992baa72dbf","relate_stocks":{"HSI":"恒生指数"},"source_url":"","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1184540436","content_text":"9月1日，香港交易所宣布，由于八号台风信号现正生效，今天（星期五）的证券及衍生产品市场全日暂停交易，包括收市后交易时段。所有证券结算及交收服务今天亦暂停。沪深股通今天亦暂停。","news_type":1},"isVote":1,"tweetType":1,"viewCount":995,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":212862152908920,"gmtCreate":1693008009751,"gmtModify":1693008011493,"author":{"id":"3479576576056160","authorId":"3479576576056160","name":"东东南亚","avatar":"https://static.tigerbbs.com/d8c94e66f07db4943f9b584d30f6937f","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3479576576056160","authorIdStr":"3479576576056160"},"themes":[],"htmlText":"不要被金钱冲昏头脑，专注创新和发展，人工智能领域前景广阔，人类的进步不应止于此。","listText":"不要被金钱冲昏头脑，专注创新和发展，人工智能领域前景广阔，人类的进步不应止于此。","text":"不要被金钱冲昏头脑，专注创新和发展，人工智能领域前景广阔，人类的进步不应止于此。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/212862152908920","repostId":"1101234377","repostType":2,"repost":{"id":"1101234377","pubTimestamp":1692954450,"share":"https://www.laohu8.com/m/news/1101234377?lang=&edition=full","pubTime":"2023-08-25 17:07","market":"us","language":"zh","title":"意外，英伟达宣布250亿美元回购传递了什么信号？","url":"https://stock-news.laohu8.com/highlight/detail?id=1101234377","media":"新浪科技","summary":"英伟达的管理层认为其股价被低估了。","content":"<html><head></head><body><p>　　尽管英伟达第二季度的业绩令股东备受鼓舞，但该公司在今年股价上涨超过两倍后，却依然回购250亿美元的决定，令许多股东措手不及。</p><p style=\"text-align: start;\">　　由于人工智能热潮推升了英伟达芯片的市场需求，刺激该公司最新一个季度的营收超出预期，推动该股周四触及历史新高。</p><p style=\"text-align: start;\">　　英伟达股价在财报发布前几天一直上涨，周四当天涨幅也超过6%，但收盘时略有收窄。</p><p style=\"text-align: start;\">　　然而，英伟达当天宣布的股票回购计划却令投资者颇感意外。根据EPFR的统计，这在美国企业今年宣布的股票回购计划中位居第五。</p><p style=\"text-align: start;\">　　企业通常将回购股票作为向股东返还资本的一种方式。由于这类回购可以减少股票供给和增加需求，而且能够提升每股收益，因而通常对股价形成利好。</p><p style=\"text-align: start;\">　　<strong>投资者通常将股票回购视作企业股价被低估的重要信号，但英伟达的股价今年涨幅已经达到220%，导致投资者很难理解背后的逻辑。</strong></p><p style=\"text-align: start;\">　　“这有点令人费解。”Avenue资产管理公司首席策略师金·利普（King Lip）说，该公司管理的资产规模达到25亿美元，英伟达是其十大持仓股之一。</p><p style=\"text-align: start;\">　　<strong>“作为股东，我们愿意看到股票回购。但对于英伟达这样一家增速如此之快的公司，你可能更希望他们用利润来推动公司发展。”利普补充道。</strong></p><p style=\"text-align: start;\">　　Synovus Trust高级投资组合经理丹尼尔·摩根（Daniel Morgan）表示，有些公司的财务业绩增长缓慢，于是选择通过回购来提振每股收益，英伟达则是“热门的成长型科技公司”，所以他们的声明“令人意外”。Synovus Trust持有英伟达股票。</p><p style=\"text-align: start;\">　　<strong>“他们传递的信息似乎是，英伟达的管理层认为其股价被低估了。”摩根说。</strong></p><p style=\"text-align: start;\">　　<strong>对部分投资者来说，“英伟达被低估了”似乎是一条很难接受的信息。数据显示，截至周三，英伟达股票的12个月预期市盈率为45倍，而标普500平均市盈率约为19倍。</strong></p><p style=\"text-align: start;\">　　“根据历史经验，当一家公司在股价低迷时回购股票，可以取悦投资者。但我不认为现在有任何人可以证明该股低迷。”Plumb Funds首席投资组合经理兼CEO汤姆·普拉姆（Tom Plumb）说。</p><p style=\"text-align: start;\">　　但普拉姆表示，在英伟达洽购ARM的交易去年因为监管问题而失败后，该公司的资源配置方式便受到局限。</p><p style=\"text-align: start;\">　　“他们手握巨额现金，超过了目前的战略投资需求，他们被禁止收购重要的互补性企业。”他说，“既然如此，他们还能用现金干什么呢？”</p><p style=\"text-align: start;\">　　英伟达去年的研发投入约占其营收的27%，与竞争对手相当。</p><p style=\"text-align: start;\">　　该公司尚未对此置评。</p><p style=\"text-align: start;\">　　英伟达在第二季财报中表示，其董事会批准追加250亿美元“无限期”股票回购计划。</p><p style=\"text-align: start;\">　　尽管金额惊人，但截至周三，英伟达一年内的回购金额仅占其1.2万亿美元市值的2.1%，低于标普500成分股2.58%的历史回购率。</p><p style=\"text-align: start;\">　　其他科技巨头也宣布了规模更大的股票回购计划：苹果(176.38, -4.74, -2.62%)为900亿美元，Alphabet为700亿美元，Meta Platforms也达到400亿美元。</p><p style=\"text-align: start;\">　　Houlihan Lokey美国股市咨询主管丹尼尔·克劳斯纳（Daniel Klausner）表示，科技公司更愿意利用手头的现金回购股票，而非派发股息，因为“如果每个季度都要派息，可能会阻碍其把握增长机遇的能力。”</p><p style=\"text-align: start;\">　　的确有一些投资者对英伟达的回购表示欢迎。</p><p style=\"text-align: start;\">　　“这体现了信心。”F/M Investments大盘股基金高级投资组合经理弗朗西斯科·比多（Francisco Bido）说，“如果能有更好的办法利用现金，我相信他们肯定会这么做的。”</p></body></html>","source":"sina_tech","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>意外，英伟达宣布250亿美元回购传递了什么信号？</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n意外，英伟达宣布250亿美元回购传递了什么信号？\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-08-25 17:07 北京时间&nbsp;&nbsp;&nbsp;<a href=https://finance.sina.com.cn/stock/usstock/c/2023-08-25/doc-imzimcvz8711542.shtml><strong>新浪科技</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>尽管英伟达第二季度的业绩令股东备受鼓舞，但该公司在今年股价上涨超过两倍后，却依然回购250亿美元的决定，令许多股东措手不及。　　由于人工智能热潮推升了英伟达芯片的市场需求，刺激该公司最新一个季度的营收超出预期，推动该股周四触及历史新高。　　英伟达股价在财报发布前几天一直上涨，周四当天涨幅也超过6%，但收盘时略有收窄。　　然而，英伟达当天宣布的股票回购计划却令投资者颇感意外。根据EPFR的统计，这在...</p>\n\n<a href=\"https://finance.sina.com.cn/stock/usstock/c/2023-08-25/doc-imzimcvz8711542.shtml\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/7d047358e0af1920417573b07259e5f2","relate_stocks":{"NVDA":"英伟达"},"source_url":"https://finance.sina.com.cn/stock/usstock/c/2023-08-25/doc-imzimcvz8711542.shtml","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1101234377","content_text":"尽管英伟达第二季度的业绩令股东备受鼓舞，但该公司在今年股价上涨超过两倍后，却依然回购250亿美元的决定，令许多股东措手不及。　　由于人工智能热潮推升了英伟达芯片的市场需求，刺激该公司最新一个季度的营收超出预期，推动该股周四触及历史新高。　　英伟达股价在财报发布前几天一直上涨，周四当天涨幅也超过6%，但收盘时略有收窄。　　然而，英伟达当天宣布的股票回购计划却令投资者颇感意外。根据EPFR的统计，这在美国企业今年宣布的股票回购计划中位居第五。　　企业通常将回购股票作为向股东返还资本的一种方式。由于这类回购可以减少股票供给和增加需求，而且能够提升每股收益，因而通常对股价形成利好。　　投资者通常将股票回购视作企业股价被低估的重要信号，但英伟达的股价今年涨幅已经达到220%，导致投资者很难理解背后的逻辑。　　“这有点令人费解。”Avenue资产管理公司首席策略师金·利普（King Lip）说，该公司管理的资产规模达到25亿美元，英伟达是其十大持仓股之一。　　“作为股东，我们愿意看到股票回购。但对于英伟达这样一家增速如此之快的公司，你可能更希望他们用利润来推动公司发展。”利普补充道。　　Synovus Trust高级投资组合经理丹尼尔·摩根（Daniel Morgan）表示，有些公司的财务业绩增长缓慢，于是选择通过回购来提振每股收益，英伟达则是“热门的成长型科技公司”，所以他们的声明“令人意外”。Synovus Trust持有英伟达股票。　　“他们传递的信息似乎是，英伟达的管理层认为其股价被低估了。”摩根说。　　对部分投资者来说，“英伟达被低估了”似乎是一条很难接受的信息。数据显示，截至周三，英伟达股票的12个月预期市盈率为45倍，而标普500平均市盈率约为19倍。　　“根据历史经验，当一家公司在股价低迷时回购股票，可以取悦投资者。但我不认为现在有任何人可以证明该股低迷。”Plumb Funds首席投资组合经理兼CEO汤姆·普拉姆（Tom Plumb）说。　　但普拉姆表示，在英伟达洽购ARM的交易去年因为监管问题而失败后，该公司的资源配置方式便受到局限。　　“他们手握巨额现金，超过了目前的战略投资需求，他们被禁止收购重要的互补性企业。”他说，“既然如此，他们还能用现金干什么呢？”　　英伟达去年的研发投入约占其营收的27%，与竞争对手相当。　　该公司尚未对此置评。　　英伟达在第二季财报中表示，其董事会批准追加250亿美元“无限期”股票回购计划。　　尽管金额惊人，但截至周三，英伟达一年内的回购金额仅占其1.2万亿美元市值的2.1%，低于标普500成分股2.58%的历史回购率。　　其他科技巨头也宣布了规模更大的股票回购计划：苹果(176.38, -4.74, -2.62%)为900亿美元，Alphabet为700亿美元，Meta Platforms也达到400亿美元。　　Houlihan Lokey美国股市咨询主管丹尼尔·克劳斯纳（Daniel Klausner）表示，科技公司更愿意利用手头的现金回购股票，而非派发股息，因为“如果每个季度都要派息，可能会阻碍其把握增长机遇的能力。”　　的确有一些投资者对英伟达的回购表示欢迎。　　“这体现了信心。”F/M Investments大盘股基金高级投资组合经理弗朗西斯科·比多（Francisco Bido）说，“如果能有更好的办法利用现金，我相信他们肯定会这么做的。”","news_type":1},"isVote":1,"tweetType":1,"viewCount":1252,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":212189702062136,"gmtCreate":1692822805880,"gmtModify":1692822806924,"author":{"id":"3479576576056160","authorId":"3479576576056160","name":"东东南亚","avatar":"https://static.tigerbbs.com/d8c94e66f07db4943f9b584d30f6937f","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3479576576056160","authorIdStr":"3479576576056160"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/NVDA\">$英伟达(NVDA)$&nbsp;</a>重要提示！英伟达现在可以卖房买了！ <a href=\"https://laohu8.com/S/TSLA\">$特斯拉(TSLA)$&nbsp;</a><a href=\"https://laohu8.com/S/MSFT\">$微软(MSFT)$&nbsp;</a>","listText":"<a href=\"https://laohu8.com/S/NVDA\">$英伟达(NVDA)$&nbsp;</a>重要提示！英伟达现在可以卖房买了！ <a href=\"https://laohu8.com/S/TSLA\">$特斯拉(TSLA)$&nbsp;</a><a href=\"https://laohu8.com/S/MSFT\">$微软(MSFT)$&nbsp;</a>","text":"$英伟达(NVDA)$ 重要提示！英伟达现在可以卖房买了！ $特斯拉(TSLA)$ $微软(MSFT)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":5,"repostSize":0,"link":"https://laohu8.com/post/212189702062136","isVote":1,"tweetType":1,"viewCount":3406,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3554542575382015","authorId":"3554542575382015","name":"湖心渺渺长空低","avatar":"https://static.tigerbbs.com/6c97b068b07799b8b81c0196ec43dc59","crmLevel":5,"crmLevelSwitch":0,"idStr":"3554542575382015","authorIdStr":"3554542575382015"},"content":"是买英伟达还是特斯拉","text":"是买英伟达还是特斯拉","html":"是买英伟达还是特斯拉"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":212137801765080,"gmtCreate":1692822299892,"gmtModify":1692822301016,"author":{"id":"3479576576056160","authorId":"3479576576056160","name":"东东南亚","avatar":"https://static.tigerbbs.com/d8c94e66f07db4943f9b584d30f6937f","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3479576576056160","authorIdStr":"3479576576056160"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/NVDA\">$英伟达(NVDA)$&nbsp;</a> 英伟达INVDA.0/2024财年第二季度营收135.1亿美元，上年同期67亿美元，，市场预期112.24亿美元。","listText":"<a href=\"https://laohu8.com/S/NVDA\">$英伟达(NVDA)$&nbsp;</a> 英伟达INVDA.0/2024财年第二季度营收135.1亿美元，上年同期67亿美元，，市场预期112.24亿美元。","text":"$英伟达(NVDA)$ 英伟达INVDA.0/2024财年第二季度营收135.1亿美元，上年同期67亿美元，，市场预期112.24亿美元。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/212137801765080","isVote":1,"tweetType":1,"viewCount":1072,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":651692545,"gmtCreate":1681805350788,"gmtModify":1681805588082,"author":{"id":"3479576576056160","authorId":"3479576576056160","name":"东东南亚","avatar":"https://static.tigerbbs.com/d8c94e66f07db4943f9b584d30f6937f","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3479576576056160","authorIdStr":"3479576576056160"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/FUT/BTCmain\">$CME比特币主连 2304(BTCmain)$&nbsp;</a><a href=\"https://laohu8.com/S/RIOT\">$Riot Blockchain, Inc.(RIOT)$&nbsp;</a><a href=\"https://laohu8.com/S/COIN\">$Coinbase Global, Inc.(COIN)$&nbsp;</a> 大饼近期趋势震荡下行，以下市场消息均不利于加密货币近期走势。 1.国际清算银行行长，利率可能需要保持在更高水平，而且持续的时间可能比此前预期的要长。 2.【苹果与高盛合作的Apple Card高收益储蓄账户今日上线】金十数据4月17日讯，苹果公司官网4月17日宣布，与高盛合作的Apple Card高收益储蓄账户于今日上线，目前提供4.15%的年利率。一旦用户通过Apple Card设置了储蓄账户，来自Apple Card的每日奖励金会自动存入该账户。用户还可以通过一个关联的银行账户将资金存入储蓄账户，并且可以随时将资金转出到关联的银行账户，过程不收取任何费用。","listText":"<a href=\"https://laohu8.com/FUT/BTCmain\">$CME比特币主连 2304(BTCmain)$&nbsp;</a><a href=\"https://laohu8.com/S/RIOT\">$Riot Blockchain, Inc.(RIOT)$&nbsp;</a><a href=\"https://laohu8.com/S/COIN\">$Coinbase Global, Inc.(COIN)$&nbsp;</a> 大饼近期趋势震荡下行，以下市场消息均不利于加密货币近期走势。 1.国际清算银行行长，利率可能需要保持在更高水平，而且持续的时间可能比此前预期的要长。 2.【苹果与高盛合作的Apple Card高收益储蓄账户今日上线】金十数据4月17日讯，苹果公司官网4月17日宣布，与高盛合作的Apple Card高收益储蓄账户于今日上线，目前提供4.15%的年利率。一旦用户通过Apple Card设置了储蓄账户，来自Apple Card的每日奖励金会自动存入该账户。用户还可以通过一个关联的银行账户将资金存入储蓄账户，并且可以随时将资金转出到关联的银行账户，过程不收取任何费用。","text":"$CME比特币主连 2304(BTCmain)$ $Riot Blockchain, Inc.(RIOT)$ $Coinbase Global, Inc.(COIN)$ 大饼近期趋势震荡下行，以下市场消息均不利于加密货币近期走势。 1.国际清算银行行长，利率可能需要保持在更高水平，而且持续的时间可能比此前预期的要长。 2.【苹果与高盛合作的Apple Card高收益储蓄账户今日上线】金十数据4月17日讯，苹果公司官网4月17日宣布，与高盛合作的Apple Card高收益储蓄账户于今日上线，目前提供4.15%的年利率。一旦用户通过Apple Card设置了储蓄账户，来自Apple Card的每日奖励金会自动存入该账户。用户还可以通过一个关联的银行账户将资金存入储蓄账户，并且可以随时将资金转出到关联的银行账户，过程不收取任何费用。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/651692545","isVote":1,"tweetType":1,"viewCount":1584,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":807466328,"gmtCreate":1628051040664,"gmtModify":1628051040664,"author":{"id":"3479576576056160","authorId":"3479576576056160","name":"东东南亚","avatar":"https://static.tigerbbs.com/d8c94e66f07db4943f9b584d30f6937f","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3479576576056160","authorIdStr":"3479576576056160"},"themes":[],"htmlText":"扎克排名很重要，希望多发一些","listText":"扎克排名很重要，希望多发一些","text":"扎克排名很重要，希望多发一些","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/807466328","repostId":"2155841281","repostType":2,"repost":{"id":"2155841281","pubTimestamp":1627585507,"share":"https://www.laohu8.com/m/news/2155841281?lang=&edition=full","pubTime":"2021-07-30 03:05","market":"us","language":"en","title":"Analysts Estimate Novavax (NVAX) to Report a Decline in Earnings: What to Look Out for","url":"https://stock-news.laohu8.com/highlight/detail?id=2155841281","media":"Zacks","summary":"Wall Street expects a year-over-year decline in earnings on higher revenues when Novavax (NVAX) repo","content":"<html><body><p>Wall Street expects a year-over-year decline in earnings on higher revenues when Novavax (NVAX) reports results for the quarter ended June 2021. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.</p>\n<p>The earnings report, which is expected to be released on August 5, 2021, might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.</p>\n<p>While management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise.</p>\n<p><b>Zacks Consensus Estimate</b></p>\n<p>This vaccine maker is expected to post quarterly loss of $3.76 per share in its upcoming report, which represents a year-over-year change of -1153.3%.</p>\n<p>Revenues are expected to be $370.8 million, up 943.3% from the year-ago quarter.</p>\n<p><b>Estimate Revisions Trend</b></p>\n<p>The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.</p>\n<p>Investors should keep in mind that an aggregate change may not always reflect the direction of estimate revisions by each of the covering analysts.</p>\n<p><b>Earnings Whisper</b></p>\n<p>Estimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. This insight is at the core of our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction).</p>\n<p>The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.</p>\n<p>Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.</p>\n<p>A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.</p>\n<p>Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).</p>\n<p><b>How Have the Numbers Shaped Up for Novavax?</b></p>\n<p>For Novavax, the Most Accurate Estimate is the same as the Zacks Consensus Estimate, suggesting that there are no recent analyst views which differ from what have been considered to derive the consensus estimate. This has resulted in an Earnings ESP of 0%.</p>\n<p>On the other hand, the stock currently carries a Zacks Rank of #5.</p>\n<p>So, this combination makes it difficult to conclusively predict that Novavax will beat the consensus EPS estimate.</p>\n<p><b>Does Earnings Surprise History Hold Any Clue?</b></p>\n<p>Analysts often consider to what extent a company has been able to match consensus estimates in the past while calculating their estimates for its future earnings. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.</p>\n<p>For the last reported quarter, it was expected that Novavax would post a loss of $2.65 per share when it actually produced a loss of $3.05, delivering a surprise of -15.09%.</p>\n<p>Over the last four quarters, the company has beaten consensus EPS estimates just once.</p>\n<p><b>Bottom Line</b></p>\n<p>An earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.</p>\n<p>That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.</p>\n<p>Novavax doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.</p>\n<br/>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. \nClick to get this free report\n<br/> \n<br/>\nNovavax, Inc. (NVAX) : Free Stock Analysis Report\n<br/> \n<br/>\nTo read this article on Zacks.com click here.</body></html>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Analysts Estimate Novavax (NVAX) to Report a Decline in Earnings: What to Look Out for</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAnalysts Estimate Novavax (NVAX) to Report a Decline in Earnings: What to Look Out for\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-30 03:05 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/analysts-estimate-novavax-nvax-report-190507642.html><strong>Zacks</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Wall Street expects a year-over-year decline in earnings on higher revenues when Novavax (NVAX) reports results for the quarter ended June 2021. While this widely-known consensus outlook is important ...</p>\n\n<a href=\"https://finance.yahoo.com/news/analysts-estimate-novavax-nvax-report-190507642.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://s.yimg.com/uu/api/res/1.2/r3XbmSiK8NsZqGuIQaOcPA--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/uu/api/res/1.2/e0VWXB5.wUFiKGuJPPpLzg--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/a7cdcede0bb5a646be035f4a7e678781","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"source_url":"https://finance.yahoo.com/news/analysts-estimate-novavax-nvax-report-190507642.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2155841281","content_text":"Wall Street expects a year-over-year decline in earnings on higher revenues when Novavax (NVAX) reports results for the quarter ended June 2021. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.\nThe earnings report, which is expected to be released on August 5, 2021, might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.\nWhile management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise.\nZacks Consensus Estimate\nThis vaccine maker is expected to post quarterly loss of $3.76 per share in its upcoming report, which represents a year-over-year change of -1153.3%.\nRevenues are expected to be $370.8 million, up 943.3% from the year-ago quarter.\nEstimate Revisions Trend\nThe consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.\nInvestors should keep in mind that an aggregate change may not always reflect the direction of estimate revisions by each of the covering analysts.\nEarnings Whisper\nEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. This insight is at the core of our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction).\nThe Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.\nThus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.\nA positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.\nPlease note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).\nHow Have the Numbers Shaped Up for Novavax?\nFor Novavax, the Most Accurate Estimate is the same as the Zacks Consensus Estimate, suggesting that there are no recent analyst views which differ from what have been considered to derive the consensus estimate. This has resulted in an Earnings ESP of 0%.\nOn the other hand, the stock currently carries a Zacks Rank of #5.\nSo, this combination makes it difficult to conclusively predict that Novavax will beat the consensus EPS estimate.\nDoes Earnings Surprise History Hold Any Clue?\nAnalysts often consider to what extent a company has been able to match consensus estimates in the past while calculating their estimates for its future earnings. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.\nFor the last reported quarter, it was expected that Novavax would post a loss of $2.65 per share when it actually produced a loss of $3.05, delivering a surprise of -15.09%.\nOver the last four quarters, the company has beaten consensus EPS estimates just once.\nBottom Line\nAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.\nThat said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.\nNovavax doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.\nWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. \nClick to get this free report\n \n\nNovavax, Inc. (NVAX) : Free Stock Analysis Report\n \n\nTo read this article on Zacks.com click here.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1362,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":807469846,"gmtCreate":1628050746185,"gmtModify":1628050746185,"author":{"id":"3479576576056160","authorId":"3479576576056160","name":"东东南亚","avatar":"https://static.tigerbbs.com/d8c94e66f07db4943f9b584d30f6937f","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3479576576056160","authorIdStr":"3479576576056160"},"themes":[],"htmlText":"一切看成果，没有成果的事情都是耍流氓。","listText":"一切看成果，没有成果的事情都是耍流氓。","text":"一切看成果，没有成果的事情都是耍流氓。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/807469846","repostId":"1124757232","repostType":2,"repost":{"id":"1124757232","pubTimestamp":1628045612,"share":"https://www.laohu8.com/m/news/1124757232?lang=&edition=full","pubTime":"2021-08-04 10:53","market":"us","language":"en","title":"3 COVID Stocks That Could Soar Higher","url":"https://stock-news.laohu8.com/highlight/detail?id=1124757232","media":"The Motley Fool","summary":"Here's why Pfizer, Inari Medical, and Novavax shares might be more valuable in 2021.\nKey Points\n\nPfi","content":"<p><b><i>Here's why Pfizer, Inari Medical, and Novavax shares might be more valuable in 2021.</i></b></p>\n<p><b>Key Points</b></p>\n<ul>\n <li>Pfizer might surprise to the upside.</li>\n <li>Inari Medical is growing like gangbusters.</li>\n <li>Novavax's vaccine might be an important booster shot as the COVID-19 virus mutates.</li>\n</ul>\n<p>COVID-19 and the international lockdown crashed the world economy in 2020. Many people have already been vaccinated and are looking forward to normalization. But COVID is mutating, and the new delta variant might toss a wrench into the world's reopening. How might investors protect themselves?</p>\n<p>A panel of Motley Fool contributors offers three ideas for healthcare stocks that will zoom higher in 2021, even if COVID takes a turn for the worse. Read more to see why you might want to buy shares of&nbsp;<b><a href=\"https://laohu8.com/S/PFE\">Pfizer</a></b>,&nbsp;<b><a href=\"https://laohu8.com/S/NARI\">Inari Medical, Inc.</a></b>, and&nbsp;<b><a href=\"https://laohu8.com/S/NVAX\">Novavax</a></b>.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/f3ed6a343e35e121aafbaa2b30134955\" tg-width=\"2000\" tg-height=\"1333\" width=\"100%\" height=\"auto\"><span>IMAGE SOURCE: GETTY IMAGES.</span></p>\n<h3><b>Pfizer: More room to run</b></h3>\n<p><b>George Budwell</b>&nbsp;<b>(Pfizer):</b>&nbsp;American pharma titan Pfizer might not sound like a sexy pick among the present cohort of COVID vaccine players. Wall Street's current consensus has Comirnaty, the drugmaker's vaccine -- produced in partnership with&nbsp;<a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a>&nbsp;-- losing steam from a sales perspective starting in 2022.</p>\n<p>Because of the delta variant, however, Comirnaty's commercial life could turn out to be much longer than originally expected. And while the emergence of the highly transmissible variant is obviously terrible news for society at large, Pfizer and its shareholders are probably going to benefit from this unfortunate development.</p>\n<p>There are two clear reasons to think that Pfizer's stock could move higher on the delta issue. First and foremost, the company&nbsp;announced&nbsp;that an Emergency Use Authorization submission for a booster third shot might happen as soon as this month. Second, Pfizer plans to start clinical trials for a delta-specific version of the vaccine this month.</p>\n<p>Although the Food and Drug Administration and the Centers for Disease Control and Prevention have both recently downplayed the need for booster shots, Pfizer has already put forth a compelling case for a third jab in response to the rampant spread of the delta variant and the waning efficacy of Comirnaty 6 to 12 months following full vaccination.</p>\n<p>The big picture for investors is that Pfizer's 2022 revenue might jump by as much as 9.7% compared to 2021 -- that is, if a booster shot is indeed approved and the company also successfully develops a delta-specific vaccine. By contrast, Wall Street currently has the drugmaker's top line falling by 14.8% next year relative to 2021.</p>\n<p>Where is Pfizer's stock possibly headed? If all the pieces fall into place on the vaccine front, shares ought to command a $50 handle, from a conservative standpoint. That's roughly a 17% upswing from where the drugmaker's shares presently stand, and that's not even accounting for the company's attractive 3.64% dividend yield at current levels. Put simply, Pfizer's stock would only be trading at approximately 3.5 times 2022 sales if this scenario pans out, which is a rather modest valuation for a&nbsp;dividend-paying&nbsp;big pharma stock.</p>\n<h3><b>Inari Medical: Skyrocketing Sales</b></h3>\n<p><b>Patrick Bafuma</b>&nbsp;<b>(Inari Medical):</b>&nbsp;If you are looking for a stock with staying power after tailwinds from the pandemic subside, look to Inari Medical. There were 108,000 new COVID cases on July 27, 2021 -- the most since February 5, 2021, according to&nbsp;<i>The New York Times</i>&nbsp;-- and that number was up over eight times the seven-day average at the start of July. To make things even worse, COVID not only causes difficulty breathing but also more than triples a patient's risk of disabling and potentially life-threatening blood clots. And we're still not sure if being vaccinated fully mitigates the risk of blood clots when a patient has an asymptomatic or a mild COVID infection.</p>\n<p>This seems like a good setup for a commercial-stage med-tech company that has developed minimally invasive products designed to remove large blood clots without the need for powerful clot-busting drugs. Through the use of its ClotTriever and FlowTriever devices, Inari has treated over 25,000 patients so far. Clinicians performed approximately 5,500 procedures with the company's devices in the first quarter of 2021,&nbsp;up 130% from the same quarter last year&nbsp;and about 20% higher than the fourth quarter of 2020. With about 12% of admitted COVID patients developing blood clots, and about 35,000 COVID hospitalizations in the U.S. (and rising) as of July 27, according to<i>The Times</i>, Inari is likely to see an uptick in eligible cases.</p>\n<p>Not to mention the company's results thus far for blood clots in the lung are spectacular:</p>\n<ul>\n <li>With the historic 30-day mortality rate of intermediate and high-risk blood clots in the lungs at 9.7%, Inari's 0.4% 30-day mortality rate is impressive.</li>\n <li>There's a decreased 30-day readmission rate of 6.7% versus 24.4% with the usual care.</li>\n <li>Major adverse events within 48 hours occur at only a 1.3% rate.</li>\n <li>No ICU stays are required after the procedure.</li>\n</ul>\n<p>Add it all up, and Inari's retrieval device seems like an obvious choice.</p>\n<p>The company grew first-quarter revenue at 113% year over year, and&nbsp;18% sequentially, and had gross margins of 91.9% for the first quarter of 2021. So Inari's price-to-sales ratio of 18 makes it a growth stock on sale.</p>\n<p>Inari has&nbsp;less than 5% penetrationin the $3.8 billion U.S. market, and there's also lots of room to grow in Europe, where it launched earlier this year. That means there are plenty of opportunities for this $4.5-billion market cap company. While COVID has affected many elective and semi-elective procedures, it has clearly not slowed Inari, and it could even accelerate its uptake.</p>\n<h3><b>Novavax: How high can it go?</b></h3>\n<p><b>Taylor Carmichael</b>&nbsp;<b>(Novavax):</b>&nbsp;The vaccine&nbsp;biotech&nbsp;Novavax had an amazing 2020, with its share price running up&nbsp;2,700%&nbsp;on optimism for its COVID vaccine. While the company has yet to file for an Emergency Use Authorization, it expects to do so in this quarter. So far in 2021, the stock is up 60%.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/0e7829d99a76c48579ba01c6e55fe14f\" tg-width=\"720\" tg-height=\"449\" width=\"100%\" height=\"auto\"><span>NVAX DATA BY YCHARTS.</span></p>\n<p>Positive phase 3 data for the COVID-19 vaccine sent the stock soaring early in the year, but the share price has come back down to earth as the company has suffered delays getting its vaccine to market. First there was a shortage of raw materials necessary to make the vaccine. Now the company has to prove that its various contract manufacturing facilities will keep the vaccine quality consistent across all the sites.</p>\n<p>Despite these delays, long-term investors have reasons to be bullish. Manufacturing is scaling up, with production rates expected to hit 100 million doses a month by the end of the third quarter, and 150 million doses a month by December. While many people in the U.S. have already been vaccinated, the opportunity in the rest of the world is sizable. Novavax has pre-sold 1.1 billion doses to COVAX (an international vaccine consortium), and has contracted to supply hundreds of millions of doses around the world.</p>\n<p>In the U.S., the Novavax vaccine might primarily be used as a&nbsp;booster shot&nbsp;for people who have already been vaccinated. \"They may be really the right ones for boosters,\" Dr. Luciana Borio, the acting chief scientist at the F.D.A. from 2015 to 2017, told&nbsp;<i>The New York Times</i>.</p>\n<p>Down the road, Novavax plans on combining its COVID vaccine with its flu vaccine, making aone-shot regimen. While COVID does not mutate as quickly as the flu, we've seen several mutating strains over the last year. It's likely that we will need to vaccinate more than once in the years ahead.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 COVID Stocks That Could Soar Higher</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 COVID Stocks That Could Soar Higher\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-04 10:53 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/08/03/3-covid-stocks-that-will-soar-higher/><strong>The Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Here's why Pfizer, Inari Medical, and Novavax shares might be more valuable in 2021.\nKey Points\n\nPfizer might surprise to the upside.\nInari Medical is growing like gangbusters.\nNovavax's vaccine might...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/03/3-covid-stocks-that-will-soar-higher/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药","NARI":"Inari Medical, Inc.","PFE":"辉瑞"},"source_url":"https://www.fool.com/investing/2021/08/03/3-covid-stocks-that-will-soar-higher/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1124757232","content_text":"Here's why Pfizer, Inari Medical, and Novavax shares might be more valuable in 2021.\nKey Points\n\nPfizer might surprise to the upside.\nInari Medical is growing like gangbusters.\nNovavax's vaccine might be an important booster shot as the COVID-19 virus mutates.\n\nCOVID-19 and the international lockdown crashed the world economy in 2020. Many people have already been vaccinated and are looking forward to normalization. But COVID is mutating, and the new delta variant might toss a wrench into the world's reopening. How might investors protect themselves?\nA panel of Motley Fool contributors offers three ideas for healthcare stocks that will zoom higher in 2021, even if COVID takes a turn for the worse. Read more to see why you might want to buy shares of Pfizer, Inari Medical, Inc., and Novavax.\nIMAGE SOURCE: GETTY IMAGES.\nPfizer: More room to run\nGeorge Budwell (Pfizer): American pharma titan Pfizer might not sound like a sexy pick among the present cohort of COVID vaccine players. Wall Street's current consensus has Comirnaty, the drugmaker's vaccine -- produced in partnership with BioNTech SE -- losing steam from a sales perspective starting in 2022.\nBecause of the delta variant, however, Comirnaty's commercial life could turn out to be much longer than originally expected. And while the emergence of the highly transmissible variant is obviously terrible news for society at large, Pfizer and its shareholders are probably going to benefit from this unfortunate development.\nThere are two clear reasons to think that Pfizer's stock could move higher on the delta issue. First and foremost, the company announced that an Emergency Use Authorization submission for a booster third shot might happen as soon as this month. Second, Pfizer plans to start clinical trials for a delta-specific version of the vaccine this month.\nAlthough the Food and Drug Administration and the Centers for Disease Control and Prevention have both recently downplayed the need for booster shots, Pfizer has already put forth a compelling case for a third jab in response to the rampant spread of the delta variant and the waning efficacy of Comirnaty 6 to 12 months following full vaccination.\nThe big picture for investors is that Pfizer's 2022 revenue might jump by as much as 9.7% compared to 2021 -- that is, if a booster shot is indeed approved and the company also successfully develops a delta-specific vaccine. By contrast, Wall Street currently has the drugmaker's top line falling by 14.8% next year relative to 2021.\nWhere is Pfizer's stock possibly headed? If all the pieces fall into place on the vaccine front, shares ought to command a $50 handle, from a conservative standpoint. That's roughly a 17% upswing from where the drugmaker's shares presently stand, and that's not even accounting for the company's attractive 3.64% dividend yield at current levels. Put simply, Pfizer's stock would only be trading at approximately 3.5 times 2022 sales if this scenario pans out, which is a rather modest valuation for a dividend-paying big pharma stock.\nInari Medical: Skyrocketing Sales\nPatrick Bafuma (Inari Medical): If you are looking for a stock with staying power after tailwinds from the pandemic subside, look to Inari Medical. There were 108,000 new COVID cases on July 27, 2021 -- the most since February 5, 2021, according to The New York Times -- and that number was up over eight times the seven-day average at the start of July. To make things even worse, COVID not only causes difficulty breathing but also more than triples a patient's risk of disabling and potentially life-threatening blood clots. And we're still not sure if being vaccinated fully mitigates the risk of blood clots when a patient has an asymptomatic or a mild COVID infection.\nThis seems like a good setup for a commercial-stage med-tech company that has developed minimally invasive products designed to remove large blood clots without the need for powerful clot-busting drugs. Through the use of its ClotTriever and FlowTriever devices, Inari has treated over 25,000 patients so far. Clinicians performed approximately 5,500 procedures with the company's devices in the first quarter of 2021, up 130% from the same quarter last year and about 20% higher than the fourth quarter of 2020. With about 12% of admitted COVID patients developing blood clots, and about 35,000 COVID hospitalizations in the U.S. (and rising) as of July 27, according toThe Times, Inari is likely to see an uptick in eligible cases.\nNot to mention the company's results thus far for blood clots in the lung are spectacular:\n\nWith the historic 30-day mortality rate of intermediate and high-risk blood clots in the lungs at 9.7%, Inari's 0.4% 30-day mortality rate is impressive.\nThere's a decreased 30-day readmission rate of 6.7% versus 24.4% with the usual care.\nMajor adverse events within 48 hours occur at only a 1.3% rate.\nNo ICU stays are required after the procedure.\n\nAdd it all up, and Inari's retrieval device seems like an obvious choice.\nThe company grew first-quarter revenue at 113% year over year, and 18% sequentially, and had gross margins of 91.9% for the first quarter of 2021. So Inari's price-to-sales ratio of 18 makes it a growth stock on sale.\nInari has less than 5% penetrationin the $3.8 billion U.S. market, and there's also lots of room to grow in Europe, where it launched earlier this year. That means there are plenty of opportunities for this $4.5-billion market cap company. While COVID has affected many elective and semi-elective procedures, it has clearly not slowed Inari, and it could even accelerate its uptake.\nNovavax: How high can it go?\nTaylor Carmichael (Novavax): The vaccine biotech Novavax had an amazing 2020, with its share price running up 2,700% on optimism for its COVID vaccine. While the company has yet to file for an Emergency Use Authorization, it expects to do so in this quarter. So far in 2021, the stock is up 60%.\nNVAX DATA BY YCHARTS.\nPositive phase 3 data for the COVID-19 vaccine sent the stock soaring early in the year, but the share price has come back down to earth as the company has suffered delays getting its vaccine to market. First there was a shortage of raw materials necessary to make the vaccine. Now the company has to prove that its various contract manufacturing facilities will keep the vaccine quality consistent across all the sites.\nDespite these delays, long-term investors have reasons to be bullish. Manufacturing is scaling up, with production rates expected to hit 100 million doses a month by the end of the third quarter, and 150 million doses a month by December. While many people in the U.S. have already been vaccinated, the opportunity in the rest of the world is sizable. Novavax has pre-sold 1.1 billion doses to COVAX (an international vaccine consortium), and has contracted to supply hundreds of millions of doses around the world.\nIn the U.S., the Novavax vaccine might primarily be used as a booster shot for people who have already been vaccinated. \"They may be really the right ones for boosters,\" Dr. Luciana Borio, the acting chief scientist at the F.D.A. from 2015 to 2017, told The New York Times.\nDown the road, Novavax plans on combining its COVID vaccine with its flu vaccine, making aone-shot regimen. While COVID does not mutate as quickly as the flu, we've seen several mutating strains over the last year. It's likely that we will need to vaccinate more than once in the years ahead.","news_type":1},"isVote":1,"tweetType":1,"viewCount":2030,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":163613497,"gmtCreate":1623882328519,"gmtModify":1623882328519,"author":{"id":"3479576576056160","authorId":"3479576576056160","name":"东东南亚","avatar":"https://static.tigerbbs.com/d8c94e66f07db4943f9b584d30f6937f","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3479576576056160","authorIdStr":"3479576576056160"},"themes":[],"htmlText":"嗯","listText":"嗯","text":"嗯","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/163613497","repostId":"1178463933","repostType":2,"repost":{"id":"1178463933","pubTimestamp":1623824661,"share":"https://www.laohu8.com/m/news/1178463933?lang=&edition=full","pubTime":"2021-06-16 14:24","market":"us","language":"en","title":"7 Best Growth Stocks to Buy in June","url":"https://stock-news.laohu8.com/highlight/detail?id=1178463933","media":"InvestorPlace","summary":"Growth stocks have taken an absolute beating. Let's look at a handful of the best to buy this month.","content":"<p>Growth stocks have taken an absolute beating. Let's look at a handful of the best to buy this month.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/c7d5e291cb00ad126c12d7ed57c26719\" tg-width=\"1024\" tg-height=\"576\"><span>Source: Shutterstock</span></p>\n<p></p>\n<p>It’s no secret that growth stocks have taken an absolute beating over the last couple months. In fact, even though there’s been a decent bounce from the recent low, this group has been engulfed in a brutal bear market. As a result, it’s harder to find growth stocks to buy.</p>\n<p>That’s even as other indices have hit new all-time highs, and many are sitting just below those highs. The crosscurrents we’ve experienced in the stock market via sector and asset rotation have been pretty wild over the past few months.</p>\n<p>However, these are the types of rotations we should be<i>running toward</i>— not away from.</p>\n<p>Obviously we don’t want to be buying low-quality stocks that have been obliterated. With that being said, many high-quality names were thrown out with these losing stocks. As a result, they’ve suffered declines of 30% to 50% in the past several months.</p>\n<p>I am a&nbsp;huge advocate of scooping up growth stocks&nbsp;on these types of declines. So let’s look at seven of them now.</p>\n<ul>\n <li><b>Roku</b>(NASDAQ:<b><u>ROKU</u></b>)</li>\n <li><b>Square</b>(NYSE:<b><u>SQ</u></b>)</li>\n <li><b>Sea Ltd</b>(NYSE:<b><u>SE</u></b>)</li>\n <li><b>Twilio</b>(NYSE:<b><u>TWLO</u></b>)</li>\n <li><b>Snap</b>(NYSE:<b><u>SNAP</u></b>)</li>\n <li><b>The Trade Desk</b>(NASDAQ:<b><u>TTD</u></b>)</li>\n <li><b>Shopify</b>(NYSE:<b><u>SHOP</u></b>)</li>\n</ul>\n<p><b>Roku (ROKU)</b></p>\n<p>With its move from sub-$30 in late 2018 to its recent high of almost $500, Roku has firmly cemented itself into the next generation of growth stocks. Will it grow to be the next&nbsp;<b>Apple</b>(NASDAQ:<b><u>AAPL</u></b>)? In terms of market capitalization, probably not.</p>\n<p>However, it’s firmly entrenched in a major secular growth trend. Streaming TV is not going away. It’s too convenient for customers and offers too many options to be discarded. It’s simply the new way that we digest video and Roku’s leading the charge.</p>\n<p>Too many people keep thinking of Roku as the streaming stick you put in the TV or as the smart TV you buy from the store. That’s Roku’s hardware unit, but it’s the wrong focus. The hardware is simply the gateway to the company’s<i>platform</i>.</p>\n<p>The platform has all of the leverage. It’s what’s powering the big move in gross profit, revenue growth and usage. It’s why Roku has an enormous runway of growth both domestically and internationally. Despite years to get the story right, look at how conservative the analysts remain.</p>\n<p>Revenue of $574 million&nbsp;beat estimates by almost $83 million, nearly 17% higher than consensus estimates, and was up almost 80% year over year. A surprise profit of 54 cents per share crushed expectations by 67 cents. Revenue estimates for next quarter torched expectations as well ($615 million at the midpoint vs. expectations of $546 million).</p>\n<p><b>Square (SQ)</b></p>\n<p>What do I love about Square? It’s continued push toward new technologies and features. It’s not shy about disrupting a particular space, nor does it seem worried about angering the legacy providers in various industries.</p>\n<p>It’s quickly becoming a go-to platform — there’s that word again,<i>platform</i>— for all things money.</p>\n<p>Whether you’re a small- or medium-sized business or just a single person looking to send some money, Square has various solutions at hand. Business lending, recurring revenue via point-of-service, its Cash App, payroll services, cryptocurrency trading — you name it.</p>\n<p>It’s why so many investors continue to hold this name, believing that it has a long runway of growth as it continues to gain customers.</p>\n<p>The other thing I like about Square? How well it held up during the bear market correction. Shares fell “just” 20% from peak to trough. While shedding a fifth of its value seems rough, it’s<i>much</i>better than its peers held up. Almost all of these stocks fell 40% or more. It’s even more impressive considering that Square rallied more than 250% from the March 2020 lows and it didn’t break its March lows (again, like most of its peers did in May).</p>\n<p><b>Sea Ltd (SE)</b></p>\n<p>Another stock that had impressive relative strength was Sea Ltd. In fact, this stock had a very similar performance run as Square.</p>\n<p>Shares rallied 500% from the March 2020 low to the February high and then corrected 27%. Sea stock is now only about $5 from its all-time high. This stock is incredibly resilient. Further, it’s got the growth to back it up.</p>\n<p>Analysts expect&nbsp;85% revenue growth this year and 46% growth in 2022. On the earnings front, analysts expect a loss in each of the next two years, but Sea is forecast to shrink those losses in both years.</p>\n<p>Now it’s looking to&nbsp;expand in South America too, further helping drive its growth higher.</p>\n<p>I can’t believe how well the stock has held up after such a strong run and rapid rebound. This one has plenty of relative strength.</p>\n<p><b>Twilio (TWLO)</b></p>\n<p>One of the highest-quality companies on this list, Twilio has become a growth giant. Like Roku, it wasn’t long ago that Twilio was trading below $40. Heck, at its recent low, Twilio shares were trading below $100. At its recent high though, the stock was north of $450.</p>\n<p>Twilio has become<i>the</i>premiere platform for businesses to communicate with their customers.Everyone from ride-sharing companies to&nbsp;<b>Airbnb</b>(NASDAQ:<b><u>ABNB</u></b>) to&nbsp;<b>Twitter</b>(NYSE:<b><u>TWTR</u></b>) use Twilio to communicate with customers and users, with plenty of others in between.</p>\n<p>In the world of growth, we have speculative growth stocks and established growth stocks. While it’s rewarding to catching the speculative winners that turn into the future growth giants, Twilio is an established growth giant.</p>\n<p>Its acquisition of SendGrid took Twilio to the next level by incorporating email into the communication strategy. The company is leveraging the internet and mobile devices for communication, and unless we stop traveling, buying, tweeting and other things, Twilio will be here for years and years to come.</p>\n<p><b>Snap (SNAP)</b></p>\n<p>Snap is one of Wall Street’s favorite social media giants.<b>Facebook</b>(NASDAQ:<b><u>FB</u></b>) has garnered some nice momentum lately, but Snap is absolutely one that investors will come back to and bid higher if growth stocks fetch a bid.</p>\n<p>While it took a few years for this young company to find its way, management has done so in an impressive manner. Consensus estimates now call for 55% revenue growth this year, near-50% growth in 2022 and more than 40% growth in 2023.</p>\n<p>If those estimates pan out, it will take Snap from $2.5 billion in sales in 2020 to more than $8 billion in revenue in 2024. Whoa! Now you can see where the bullish case comes from with this one.</p>\n<p>Making things even better, the company is forecast to become profitable this year, then more than triple its earnings in 2022.</p>\n<p>We’ll see how accurate some of these estimates are. But one thing seems certain and that’s that Snapchat isn’t going anywhere and it should be a significant driver of growth for the next several years.</p>\n<p>Like Square, Snap didn’t break down to new lows this quarter and fell “just” 28% from the high. Let’s see how long it takes to erase the current 10% dip from the highs.</p>\n<p><b>The Trade Desk (TTD)</b></p>\n<p>Now this one is truly perplexing. The Trade Desk became a Wall Street favorite, surging from about $150 in March 2020 to almost $1,000 by December.</p>\n<p>After a move like that, I don’t care how great the company is — the stock deserves to correct. Of course, The Trade Desk was also trading at more than 40 times revenue, which made it susceptible to the “snowball selloff” or a decline that gains serious momentum on the way down once investors discover a reason to sell it.</p>\n<p>Despite the bumpy price action, including a 50% correction off the highs, this stock looks like a bargain on the dip. Why? Because it’s a fantastic business!</p>\n<p>Co-founder and CEO Jeff Green has built a remarkable business, one that is thriving around the world — including China. That’s a big difference vs. some of the ad giants of the world, like&nbsp;<b>Alphabet</b>(NASDAQ:<b><u>GOOGL</u></b>, NASDAQ:<b><u>GOOG</u></b>) and Facebook, which aren’t allowed to operate in China.</p>\n<p>The company&nbsp;uses data to spread contracted products to reach as many potential customers as possible. As online advertising continues to grow and as advertising on streaming TV grows, so too should The Trade Desk.</p>\n<p>Perhaps one of my favorite things about this company? The cash flow and the bottom line. Despite being a growth company, this company still generates solid earnings. I expect The Trade Desk to&nbsp;generate 30%-plus revenue growth&nbsp;in each of the next three years, minimum.</p>\n<p><b>Shopify (SHOP)</b></p>\n<p>Shopify isn’t exactly flying under the radar these days. The company commands a market cap of $163 billion, making it a large cap tech stock.</p>\n<p>I wrote about this one in Dec. 2019, back when it had a $30 billion to $40 billion market cap. My case was based on the idea of the&nbsp;stock tripling in the next five to 10 years. I was certainly bullish on this stock, but clearly not bullish enough.</p>\n<p>Put simply, Shopify is revolutionizing and completely disrupting the e-commerce space. Yeah, there’s&nbsp;<b>Amazon</b>(NASDAQ:<b><u>AMZN</u></b>), but there’s enough room for two of these beasts.</p>\n<p>Shopify will have its share of ups and downs, but it’s not going anywhere soon. It’s built a can’t-live-without platform for its customers and it’s not even close to being done yet. The valuation is high, but the growth seems endless.</p>\n<p>Like others on this list, Shopify held up pretty well during the selloff. I wouldn’t hesitate to hold this name long term and take advantage of the dips.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>7 Best Growth Stocks to Buy in June</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n7 Best Growth Stocks to Buy in June\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-16 14:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/06/7-best-growth-stocks-to-buy-in-june/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Growth stocks have taken an absolute beating. Let's look at a handful of the best to buy this month.\nSource: Shutterstock\n\nIt’s no secret that growth stocks have taken an absolute beating over the ...</p>\n\n<a href=\"https://investorplace.com/2021/06/7-best-growth-stocks-to-buy-in-june/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TWLO":"Twilio Inc","SQ":"Block","TTD":"Trade Desk Inc.","SHOP":"Shopify Inc","SE":"Sea Ltd","ROKU":"Roku Inc","SNAP":"Snap Inc"},"source_url":"https://investorplace.com/2021/06/7-best-growth-stocks-to-buy-in-june/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1178463933","content_text":"Growth stocks have taken an absolute beating. Let's look at a handful of the best to buy this month.\nSource: Shutterstock\n\nIt’s no secret that growth stocks have taken an absolute beating over the last couple months. In fact, even though there’s been a decent bounce from the recent low, this group has been engulfed in a brutal bear market. As a result, it’s harder to find growth stocks to buy.\nThat’s even as other indices have hit new all-time highs, and many are sitting just below those highs. The crosscurrents we’ve experienced in the stock market via sector and asset rotation have been pretty wild over the past few months.\nHowever, these are the types of rotations we should berunning toward— not away from.\nObviously we don’t want to be buying low-quality stocks that have been obliterated. With that being said, many high-quality names were thrown out with these losing stocks. As a result, they’ve suffered declines of 30% to 50% in the past several months.\nI am a huge advocate of scooping up growth stocks on these types of declines. So let’s look at seven of them now.\n\nRoku(NASDAQ:ROKU)\nSquare(NYSE:SQ)\nSea Ltd(NYSE:SE)\nTwilio(NYSE:TWLO)\nSnap(NYSE:SNAP)\nThe Trade Desk(NASDAQ:TTD)\nShopify(NYSE:SHOP)\n\nRoku (ROKU)\nWith its move from sub-$30 in late 2018 to its recent high of almost $500, Roku has firmly cemented itself into the next generation of growth stocks. Will it grow to be the next Apple(NASDAQ:AAPL)? In terms of market capitalization, probably not.\nHowever, it’s firmly entrenched in a major secular growth trend. Streaming TV is not going away. It’s too convenient for customers and offers too many options to be discarded. It’s simply the new way that we digest video and Roku’s leading the charge.\nToo many people keep thinking of Roku as the streaming stick you put in the TV or as the smart TV you buy from the store. That’s Roku’s hardware unit, but it’s the wrong focus. The hardware is simply the gateway to the company’splatform.\nThe platform has all of the leverage. It’s what’s powering the big move in gross profit, revenue growth and usage. It’s why Roku has an enormous runway of growth both domestically and internationally. Despite years to get the story right, look at how conservative the analysts remain.\nRevenue of $574 million beat estimates by almost $83 million, nearly 17% higher than consensus estimates, and was up almost 80% year over year. A surprise profit of 54 cents per share crushed expectations by 67 cents. Revenue estimates for next quarter torched expectations as well ($615 million at the midpoint vs. expectations of $546 million).\nSquare (SQ)\nWhat do I love about Square? It’s continued push toward new technologies and features. It’s not shy about disrupting a particular space, nor does it seem worried about angering the legacy providers in various industries.\nIt’s quickly becoming a go-to platform — there’s that word again,platform— for all things money.\nWhether you’re a small- or medium-sized business or just a single person looking to send some money, Square has various solutions at hand. Business lending, recurring revenue via point-of-service, its Cash App, payroll services, cryptocurrency trading — you name it.\nIt’s why so many investors continue to hold this name, believing that it has a long runway of growth as it continues to gain customers.\nThe other thing I like about Square? How well it held up during the bear market correction. Shares fell “just” 20% from peak to trough. While shedding a fifth of its value seems rough, it’smuchbetter than its peers held up. Almost all of these stocks fell 40% or more. It’s even more impressive considering that Square rallied more than 250% from the March 2020 lows and it didn’t break its March lows (again, like most of its peers did in May).\nSea Ltd (SE)\nAnother stock that had impressive relative strength was Sea Ltd. In fact, this stock had a very similar performance run as Square.\nShares rallied 500% from the March 2020 low to the February high and then corrected 27%. Sea stock is now only about $5 from its all-time high. This stock is incredibly resilient. Further, it’s got the growth to back it up.\nAnalysts expect 85% revenue growth this year and 46% growth in 2022. On the earnings front, analysts expect a loss in each of the next two years, but Sea is forecast to shrink those losses in both years.\nNow it’s looking to expand in South America too, further helping drive its growth higher.\nI can’t believe how well the stock has held up after such a strong run and rapid rebound. This one has plenty of relative strength.\nTwilio (TWLO)\nOne of the highest-quality companies on this list, Twilio has become a growth giant. Like Roku, it wasn’t long ago that Twilio was trading below $40. Heck, at its recent low, Twilio shares were trading below $100. At its recent high though, the stock was north of $450.\nTwilio has becomethepremiere platform for businesses to communicate with their customers.Everyone from ride-sharing companies to Airbnb(NASDAQ:ABNB) to Twitter(NYSE:TWTR) use Twilio to communicate with customers and users, with plenty of others in between.\nIn the world of growth, we have speculative growth stocks and established growth stocks. While it’s rewarding to catching the speculative winners that turn into the future growth giants, Twilio is an established growth giant.\nIts acquisition of SendGrid took Twilio to the next level by incorporating email into the communication strategy. The company is leveraging the internet and mobile devices for communication, and unless we stop traveling, buying, tweeting and other things, Twilio will be here for years and years to come.\nSnap (SNAP)\nSnap is one of Wall Street’s favorite social media giants.Facebook(NASDAQ:FB) has garnered some nice momentum lately, but Snap is absolutely one that investors will come back to and bid higher if growth stocks fetch a bid.\nWhile it took a few years for this young company to find its way, management has done so in an impressive manner. Consensus estimates now call for 55% revenue growth this year, near-50% growth in 2022 and more than 40% growth in 2023.\nIf those estimates pan out, it will take Snap from $2.5 billion in sales in 2020 to more than $8 billion in revenue in 2024. Whoa! Now you can see where the bullish case comes from with this one.\nMaking things even better, the company is forecast to become profitable this year, then more than triple its earnings in 2022.\nWe’ll see how accurate some of these estimates are. But one thing seems certain and that’s that Snapchat isn’t going anywhere and it should be a significant driver of growth for the next several years.\nLike Square, Snap didn’t break down to new lows this quarter and fell “just” 28% from the high. Let’s see how long it takes to erase the current 10% dip from the highs.\nThe Trade Desk (TTD)\nNow this one is truly perplexing. The Trade Desk became a Wall Street favorite, surging from about $150 in March 2020 to almost $1,000 by December.\nAfter a move like that, I don’t care how great the company is — the stock deserves to correct. Of course, The Trade Desk was also trading at more than 40 times revenue, which made it susceptible to the “snowball selloff” or a decline that gains serious momentum on the way down once investors discover a reason to sell it.\nDespite the bumpy price action, including a 50% correction off the highs, this stock looks like a bargain on the dip. Why? Because it’s a fantastic business!\nCo-founder and CEO Jeff Green has built a remarkable business, one that is thriving around the world — including China. That’s a big difference vs. some of the ad giants of the world, like Alphabet(NASDAQ:GOOGL, NASDAQ:GOOG) and Facebook, which aren’t allowed to operate in China.\nThe company uses data to spread contracted products to reach as many potential customers as possible. As online advertising continues to grow and as advertising on streaming TV grows, so too should The Trade Desk.\nPerhaps one of my favorite things about this company? The cash flow and the bottom line. Despite being a growth company, this company still generates solid earnings. I expect The Trade Desk to generate 30%-plus revenue growth in each of the next three years, minimum.\nShopify (SHOP)\nShopify isn’t exactly flying under the radar these days. The company commands a market cap of $163 billion, making it a large cap tech stock.\nI wrote about this one in Dec. 2019, back when it had a $30 billion to $40 billion market cap. My case was based on the idea of the stock tripling in the next five to 10 years. I was certainly bullish on this stock, but clearly not bullish enough.\nPut simply, Shopify is revolutionizing and completely disrupting the e-commerce space. Yeah, there’s Amazon(NASDAQ:AMZN), but there’s enough room for two of these beasts.\nShopify will have its share of ups and downs, but it’s not going anywhere soon. It’s built a can’t-live-without platform for its customers and it’s not even close to being done yet. The valuation is high, but the growth seems endless.\nLike others on this list, Shopify held up pretty well during the selloff. I wouldn’t hesitate to hold this name long term and take advantage of the dips.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1483,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":919869190,"gmtCreate":1576614767910,"gmtModify":1704272091633,"author":{"id":"3479576576056160","authorId":"3479576576056160","name":"东东南亚","avatar":"https://static.tigerbbs.com/d8c94e66f07db4943f9b584d30f6937f","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3479576576056160","authorIdStr":"3479576576056160"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TSLA\">$特斯拉(TSLA)$</a>重要提示<a href=\"https://laohu8.com/S/NFLX\">$Netflix, Inc.(NFLX)$</a><a href=\"https://laohu8.com/S/AAPL\">$苹果(AAPL)$</a><a href=\"https://laohu8.com/S/BRK.A\">$伯克希尔(BRK.A)$</a><a href=\"https://laohu8.com/S/BABA\">$阿里巴巴(BABA)$</a><a href=\"https://laohu8.com/S/MSFT\">$微软(MSFT)$</a>特斯拉目前为历史最高点，潜在突破位置，两种可能一是回调，二是突破新高千亿市值(个人认为千亿可期)，无论从哪里看特斯拉已经是成熟企业，值得千亿市值了。总的来说目前位置是高点，持有有风险也可能有收益。不能否认这个位置肯定有很多人会选择空。现在就看是空头获胜还是多头获胜。但是从技术上来看，今年6月份到目前12月份特斯拉股价的走势及波动判断，本次新高是一定会突破的。更重要的是我认为奈飞现在是行情启动点了，2020年2月份奈飞股价大概率400往上。也就是说我判断奈飞从现在持有到明年2月份大概率事件会有30%左右的收益。","listText":"<a href=\"https://laohu8.com/S/TSLA\">$特斯拉(TSLA)$</a>重要提示<a href=\"https://laohu8.com/S/NFLX\">$Netflix, Inc.(NFLX)$</a><a href=\"https://laohu8.com/S/AAPL\">$苹果(AAPL)$</a><a href=\"https://laohu8.com/S/BRK.A\">$伯克希尔(BRK.A)$</a><a href=\"https://laohu8.com/S/BABA\">$阿里巴巴(BABA)$</a><a href=\"https://laohu8.com/S/MSFT\">$微软(MSFT)$</a>特斯拉目前为历史最高点，潜在突破位置，两种可能一是回调，二是突破新高千亿市值(个人认为千亿可期)，无论从哪里看特斯拉已经是成熟企业，值得千亿市值了。总的来说目前位置是高点，持有有风险也可能有收益。不能否认这个位置肯定有很多人会选择空。现在就看是空头获胜还是多头获胜。但是从技术上来看，今年6月份到目前12月份特斯拉股价的走势及波动判断，本次新高是一定会突破的。更重要的是我认为奈飞现在是行情启动点了，2020年2月份奈飞股价大概率400往上。也就是说我判断奈飞从现在持有到明年2月份大概率事件会有30%左右的收益。","text":"$特斯拉(TSLA)$重要提示$Netflix, Inc.(NFLX)$$苹果(AAPL)$$伯克希尔(BRK.A)$$阿里巴巴(BABA)$$微软(MSFT)$特斯拉目前为历史最高点，潜在突破位置，两种可能一是回调，二是突破新高千亿市值(个人认为千亿可期)，无论从哪里看特斯拉已经是成熟企业，值得千亿市值了。总的来说目前位置是高点，持有有风险也可能有收益。不能否认这个位置肯定有很多人会选择空。现在就看是空头获胜还是多头获胜。但是从技术上来看，今年6月份到目前12月份特斯拉股价的走势及波动判断，本次新高是一定会突破的。更重要的是我认为奈飞现在是行情启动点了，2020年2月份奈飞股价大概率400往上。也就是说我判断奈飞从现在持有到明年2月份大概率事件会有30%左右的收益。","images":[],"top":1,"highlighted":1,"essential":2,"paper":1,"likeSize":9,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/919869190","isVote":1,"tweetType":1,"viewCount":7004,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":937187767,"gmtCreate":1574821080959,"gmtModify":1704728588455,"author":{"id":"3479576576056160","authorId":"3479576576056160","name":"东东南亚","avatar":"https://static.tigerbbs.com/d8c94e66f07db4943f9b584d30f6937f","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3479576576056160","authorIdStr":"3479576576056160"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TSLA\">$特斯拉(TSLA)$</a>大锤貌似砸的是前车门，后车窗玻璃也碎了呀[疑问]","listText":"<a href=\"https://laohu8.com/S/TSLA\">$特斯拉(TSLA)$</a>大锤貌似砸的是前车门，后车窗玻璃也碎了呀[疑问]","text":"$特斯拉(TSLA)$大锤貌似砸的是前车门，后车窗玻璃也碎了呀[疑问]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/937187767","isVote":1,"tweetType":1,"viewCount":1762,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":934716059,"gmtCreate":1574448838071,"gmtModify":1704728065552,"author":{"id":"3479576576056160","authorId":"3479576576056160","name":"东东南亚","avatar":"https://static.tigerbbs.com/d8c94e66f07db4943f9b584d30f6937f","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3479576576056160","authorIdStr":"3479576576056160"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TSLA\">$特斯拉(TSLA)$</a>发点看法，不知道对不对，第四季度10万多的销售量能达到吗？国内特斯拉听说明年一月份才能交付，是不是今年第四季度表示并不能帮上什么忙吧？那么全面的销售目标我觉得有很大风险是达不到的啊。还是觉得全年目标有点风险。","listText":"<a href=\"https://laohu8.com/S/TSLA\">$特斯拉(TSLA)$</a>发点看法，不知道对不对，第四季度10万多的销售量能达到吗？国内特斯拉听说明年一月份才能交付，是不是今年第四季度表示并不能帮上什么忙吧？那么全面的销售目标我觉得有很大风险是达不到的啊。还是觉得全年目标有点风险。","text":"$特斯拉(TSLA)$发点看法，不知道对不对，第四季度10万多的销售量能达到吗？国内特斯拉听说明年一月份才能交付，是不是今年第四季度表示并不能帮上什么忙吧？那么全面的销售目标我觉得有很大风险是达不到的啊。还是觉得全年目标有点风险。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/934716059","isVote":1,"tweetType":1,"viewCount":3917,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":938469790,"gmtCreate":1571754505510,"gmtModify":1704722865454,"author":{"id":"3479576576056160","authorId":"3479576576056160","name":"东东南亚","avatar":"https://static.tigerbbs.com/d8c94e66f07db4943f9b584d30f6937f","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3479576576056160","authorIdStr":"3479576576056160"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TSLA\">$特斯拉(TSLA)$</a>今天我打算说点有价值的话了，特斯拉这个股票现在可以卖房买了！<a href=\"https://laohu8.com/S/AAPL\">$苹果(AAPL)$</a><a href=\"https://laohu8.com/S/NFLX\">$Netflix, Inc.(NFLX)$</a><a href=\"https://laohu8.com/S/BRK.A\">$伯克希尔(BRK.A)$</a><a href=\"https://laohu8.com/S/03333\">$中国恒大(03333)$</a>","listText":"<a href=\"https://laohu8.com/S/TSLA\">$特斯拉(TSLA)$</a>今天我打算说点有价值的话了，特斯拉这个股票现在可以卖房买了！<a href=\"https://laohu8.com/S/AAPL\">$苹果(AAPL)$</a><a href=\"https://laohu8.com/S/NFLX\">$Netflix, Inc.(NFLX)$</a><a href=\"https://laohu8.com/S/BRK.A\">$伯克希尔(BRK.A)$</a><a href=\"https://laohu8.com/S/03333\">$中国恒大(03333)$</a>","text":"$特斯拉(TSLA)$今天我打算说点有价值的话了，特斯拉这个股票现在可以卖房买了！$苹果(AAPL)$$Netflix, Inc.(NFLX)$$伯克希尔(BRK.A)$$中国恒大(03333)$","images":[],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":16,"commentSize":10,"repostSize":0,"link":"https://laohu8.com/post/938469790","isVote":1,"tweetType":1,"viewCount":7452,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"37958634096728","authorId":"37958634096728","name":"dongxie811","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":5,"crmLevelSwitch":0,"idStr":"37958634096728","authorIdStr":"37958634096728"},"content":"我也是这么想的，现在房子已经只剩下厕所了 [龇牙]","text":"我也是这么想的，现在房子已经只剩下厕所了 [龇牙]","html":"我也是这么想的，现在房子已经只剩下厕所了 [龇牙]"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":907521436,"gmtCreate":1561976388025,"gmtModify":1704702837912,"author":{"id":"3479576576056160","authorId":"3479576576056160","name":"东东南亚","avatar":"https://static.tigerbbs.com/d8c94e66f07db4943f9b584d30f6937f","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3479576576056160","authorIdStr":"3479576576056160"},"themes":[],"htmlText":"$特斯拉(TSLA)$ 230以下今晚买多少都赚钱！千万别错过这波，马上就出Q2创纪录后边最少还有8个点的涨幅，拿稳了最高可能触及280这波","listText":"$特斯拉(TSLA)$ 230以下今晚买多少都赚钱！千万别错过这波，马上就出Q2创纪录后边最少还有8个点的涨幅，拿稳了最高可能触及280这波","text":"$特斯拉(TSLA)$ 230以下今晚买多少都赚钱！千万别错过这波，马上就出Q2创纪录后边最少还有8个点的涨幅，拿稳了最高可能触及280这波","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/907521436","isVote":1,"tweetType":1,"viewCount":3558,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":907926628,"gmtCreate":1561501055564,"gmtModify":1704702065641,"author":{"id":"3479576576056160","authorId":"3479576576056160","name":"东东南亚","avatar":"https://static.tigerbbs.com/d8c94e66f07db4943f9b584d30f6937f","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3479576576056160","authorIdStr":"3479576576056160"},"themes":[],"htmlText":"$西部数据(WDC)$ 今天盘后怎么涨这么多？","listText":"$西部数据(WDC)$ 今天盘后怎么涨这么多？","text":"$西部数据(WDC)$ 今天盘后怎么涨这么多？","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/907926628","isVote":1,"tweetType":1,"viewCount":1610,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":450109,"gmtCreate":1553896869158,"gmtModify":1704795761339,"author":{"id":"3479576576056160","authorId":"3479576576056160","name":"东东南亚","avatar":"https://static.tigerbbs.com/d8c94e66f07db4943f9b584d30f6937f","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3479576576056160","authorIdStr":"3479576576056160"},"themes":[],"htmlText":"$特斯拉(TSLA)$ 特斯拉国内大家可能都在等国产，所以国内销售现在应该不会太多","listText":"$特斯拉(TSLA)$ 特斯拉国内大家可能都在等国产，所以国内销售现在应该不会太多","text":"$特斯拉(TSLA)$ 特斯拉国内大家可能都在等国产，所以国内销售现在应该不会太多","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/450109","isVote":1,"tweetType":1,"viewCount":2468,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":431105,"gmtCreate":1552687811929,"gmtModify":1704793276633,"author":{"id":"3479576576056160","authorId":"3479576576056160","name":"东东南亚","avatar":"https://static.tigerbbs.com/d8c94e66f07db4943f9b584d30f6937f","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3479576576056160","authorIdStr":"3479576576056160"},"themes":[],"htmlText":"$特斯拉(TSLA)$ 昨晚特斯拉美股大跌榜排名第十，真牛掰","listText":"$特斯拉(TSLA)$ 昨晚特斯拉美股大跌榜排名第十，真牛掰","text":"$特斯拉(TSLA)$ 昨晚特斯拉美股大跌榜排名第十，真牛掰","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/431105","isVote":1,"tweetType":1,"viewCount":2000,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":430149,"gmtCreate":1552657604724,"gmtModify":1704793152884,"author":{"id":"3479576576056160","authorId":"3479576576056160","name":"东东南亚","avatar":"https://static.tigerbbs.com/d8c94e66f07db4943f9b584d30f6937f","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3479576576056160","authorIdStr":"3479576576056160"},"themes":[],"htmlText":"$特斯拉(TSLA)$ 我还就真杠上了，打死我也不卖，有种你就跌吧","listText":"$特斯拉(TSLA)$ 我还就真杠上了，打死我也不卖，有种你就跌吧","text":"$特斯拉(TSLA)$ 我还就真杠上了，打死我也不卖，有种你就跌吧","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":6,"repostSize":0,"link":"https://laohu8.com/post/430149","isVote":1,"tweetType":1,"viewCount":1912,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"165243741689016","authorId":"165243741689016","name":"悠悠de梦","avatar":"https://static.tigerbbs.com/176f3d39a7fd793fe3725af1abc307ff","crmLevel":8,"crmLevelSwitch":1,"idStr":"165243741689016","authorIdStr":"165243741689016"},"content":"我昨天跟你一样，最高点上车的，麻痹","text":"我昨天跟你一样，最高点上车的，麻痹","html":"我昨天跟你一样，最高点上车的，麻痹"}],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":212189702062136,"gmtCreate":1692822805880,"gmtModify":1692822806924,"author":{"id":"3479576576056160","authorId":"3479576576056160","name":"东东南亚","avatar":"https://static.tigerbbs.com/d8c94e66f07db4943f9b584d30f6937f","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3479576576056160","authorIdStr":"3479576576056160"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/NVDA\">$英伟达(NVDA)$&nbsp;</a>重要提示！英伟达现在可以卖房买了！ <a href=\"https://laohu8.com/S/TSLA\">$特斯拉(TSLA)$&nbsp;</a><a href=\"https://laohu8.com/S/MSFT\">$微软(MSFT)$&nbsp;</a>","listText":"<a href=\"https://laohu8.com/S/NVDA\">$英伟达(NVDA)$&nbsp;</a>重要提示！英伟达现在可以卖房买了！ <a href=\"https://laohu8.com/S/TSLA\">$特斯拉(TSLA)$&nbsp;</a><a href=\"https://laohu8.com/S/MSFT\">$微软(MSFT)$&nbsp;</a>","text":"$英伟达(NVDA)$ 重要提示！英伟达现在可以卖房买了！ $特斯拉(TSLA)$ $微软(MSFT)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":5,"repostSize":0,"link":"https://laohu8.com/post/212189702062136","isVote":1,"tweetType":1,"viewCount":3406,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3554542575382015","authorId":"3554542575382015","name":"湖心渺渺长空低","avatar":"https://static.tigerbbs.com/6c97b068b07799b8b81c0196ec43dc59","crmLevel":5,"crmLevelSwitch":0,"idStr":"3554542575382015","authorIdStr":"3554542575382015"},"content":"是买英伟达还是特斯拉","text":"是买英伟达还是特斯拉","html":"是买英伟达还是特斯拉"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":351513,"gmtCreate":1544504777457,"gmtModify":1704783438899,"author":{"id":"3479576576056160","authorId":"3479576576056160","name":"东东南亚","avatar":"https://static.tigerbbs.com/d8c94e66f07db4943f9b584d30f6937f","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3479576576056160","authorIdStr":"3479576576056160"},"themes":[],"title":"#2018投资大复盘#炒股盈利的一点心得！","htmlText":"#2018投资大复盘#$特斯拉(TSLA)$ 我做特斯拉的心态特别好，如果亏了，我就当作为新能源做了贡献！这种良好的心态也决定我必然不会与特斯拉分开！为了清洁能源新能源为了环境污染！ 对于特斯拉对世界汽车行业产生的影响，正如马斯克所说的那样，也如他所预测的那样，促进了汽车行业的健康发展！ 对于炒股最深刻的认识就是，不论多么看好一个企业，我们炒股永远不要忘记股票是有波动的！所以心态一定要稳，不要着急追高买入，会有低点让我们买的！心里永远记住！一定会有低点让你买进的！不要因为上涨就放弃自己的心理价位！ 特别是盘前看好的心理价位一定不要放弃，这是股市赚钱的关键，往往很多人在炒股中放弃自己的心理价位，结果往往都是很难赚到钱。","listText":"#2018投资大复盘#$特斯拉(TSLA)$ 我做特斯拉的心态特别好，如果亏了，我就当作为新能源做了贡献！这种良好的心态也决定我必然不会与特斯拉分开！为了清洁能源新能源为了环境污染！ 对于特斯拉对世界汽车行业产生的影响，正如马斯克所说的那样，也如他所预测的那样，促进了汽车行业的健康发展！ 对于炒股最深刻的认识就是，不论多么看好一个企业，我们炒股永远不要忘记股票是有波动的！所以心态一定要稳，不要着急追高买入，会有低点让我们买的！心里永远记住！一定会有低点让你买进的！不要因为上涨就放弃自己的心理价位！ 特别是盘前看好的心理价位一定不要放弃，这是股市赚钱的关键，往往很多人在炒股中放弃自己的心理价位，结果往往都是很难赚到钱。","text":"#2018投资大复盘#$特斯拉(TSLA)$ 我做特斯拉的心态特别好，如果亏了，我就当作为新能源做了贡献！这种良好的心态也决定我必然不会与特斯拉分开！为了清洁能源新能源为了环境污染！ 对于特斯拉对世界汽车行业产生的影响，正如马斯克所说的那样，也如他所预测的那样，促进了汽车行业的健康发展！ 对于炒股最深刻的认识就是，不论多么看好一个企业，我们炒股永远不要忘记股票是有波动的！所以心态一定要稳，不要着急追高买入，会有低点让我们买的！心里永远记住！一定会有低点让你买进的！不要因为上涨就放弃自己的心理价位！ 特别是盘前看好的心理价位一定不要放弃，这是股市赚钱的关键，往往很多人在炒股中放弃自己的心理价位，结果往往都是很难赚到钱。","images":[],"top":1,"highlighted":1,"essential":2,"paper":2,"likeSize":3,"commentSize":9,"repostSize":0,"link":"https://laohu8.com/post/351513","isVote":1,"tweetType":1,"viewCount":4776,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"20727972514030","authorId":"20727972514030","name":"Tony特别帅","avatar":"https://static.tigerbbs.com/61f671464b0bc8103579e8d0e2197c48","crmLevel":1,"crmLevelSwitch":0,"idStr":"20727972514030","authorIdStr":"20727972514030"},"content":"评论区内容好丰富啊","text":"评论区内容好丰富啊","html":"评论区内容好丰富啊"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":938469790,"gmtCreate":1571754505510,"gmtModify":1704722865454,"author":{"id":"3479576576056160","authorId":"3479576576056160","name":"东东南亚","avatar":"https://static.tigerbbs.com/d8c94e66f07db4943f9b584d30f6937f","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3479576576056160","authorIdStr":"3479576576056160"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TSLA\">$特斯拉(TSLA)$</a>今天我打算说点有价值的话了，特斯拉这个股票现在可以卖房买了！<a href=\"https://laohu8.com/S/AAPL\">$苹果(AAPL)$</a><a href=\"https://laohu8.com/S/NFLX\">$Netflix, Inc.(NFLX)$</a><a href=\"https://laohu8.com/S/BRK.A\">$伯克希尔(BRK.A)$</a><a href=\"https://laohu8.com/S/03333\">$中国恒大(03333)$</a>","listText":"<a href=\"https://laohu8.com/S/TSLA\">$特斯拉(TSLA)$</a>今天我打算说点有价值的话了，特斯拉这个股票现在可以卖房买了！<a href=\"https://laohu8.com/S/AAPL\">$苹果(AAPL)$</a><a href=\"https://laohu8.com/S/NFLX\">$Netflix, Inc.(NFLX)$</a><a href=\"https://laohu8.com/S/BRK.A\">$伯克希尔(BRK.A)$</a><a href=\"https://laohu8.com/S/03333\">$中国恒大(03333)$</a>","text":"$特斯拉(TSLA)$今天我打算说点有价值的话了，特斯拉这个股票现在可以卖房买了！$苹果(AAPL)$$Netflix, Inc.(NFLX)$$伯克希尔(BRK.A)$$中国恒大(03333)$","images":[],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":16,"commentSize":10,"repostSize":0,"link":"https://laohu8.com/post/938469790","isVote":1,"tweetType":1,"viewCount":7452,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"37958634096728","authorId":"37958634096728","name":"dongxie811","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":5,"crmLevelSwitch":0,"idStr":"37958634096728","authorIdStr":"37958634096728"},"content":"我也是这么想的，现在房子已经只剩下厕所了 [龇牙]","text":"我也是这么想的，现在房子已经只剩下厕所了 [龇牙]","html":"我也是这么想的，现在房子已经只剩下厕所了 [龇牙]"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":919869190,"gmtCreate":1576614767910,"gmtModify":1704272091633,"author":{"id":"3479576576056160","authorId":"3479576576056160","name":"东东南亚","avatar":"https://static.tigerbbs.com/d8c94e66f07db4943f9b584d30f6937f","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3479576576056160","authorIdStr":"3479576576056160"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TSLA\">$特斯拉(TSLA)$</a>重要提示<a href=\"https://laohu8.com/S/NFLX\">$Netflix, Inc.(NFLX)$</a><a href=\"https://laohu8.com/S/AAPL\">$苹果(AAPL)$</a><a href=\"https://laohu8.com/S/BRK.A\">$伯克希尔(BRK.A)$</a><a href=\"https://laohu8.com/S/BABA\">$阿里巴巴(BABA)$</a><a href=\"https://laohu8.com/S/MSFT\">$微软(MSFT)$</a>特斯拉目前为历史最高点，潜在突破位置，两种可能一是回调，二是突破新高千亿市值(个人认为千亿可期)，无论从哪里看特斯拉已经是成熟企业，值得千亿市值了。总的来说目前位置是高点，持有有风险也可能有收益。不能否认这个位置肯定有很多人会选择空。现在就看是空头获胜还是多头获胜。但是从技术上来看，今年6月份到目前12月份特斯拉股价的走势及波动判断，本次新高是一定会突破的。更重要的是我认为奈飞现在是行情启动点了，2020年2月份奈飞股价大概率400往上。也就是说我判断奈飞从现在持有到明年2月份大概率事件会有30%左右的收益。","listText":"<a href=\"https://laohu8.com/S/TSLA\">$特斯拉(TSLA)$</a>重要提示<a href=\"https://laohu8.com/S/NFLX\">$Netflix, Inc.(NFLX)$</a><a href=\"https://laohu8.com/S/AAPL\">$苹果(AAPL)$</a><a href=\"https://laohu8.com/S/BRK.A\">$伯克希尔(BRK.A)$</a><a href=\"https://laohu8.com/S/BABA\">$阿里巴巴(BABA)$</a><a href=\"https://laohu8.com/S/MSFT\">$微软(MSFT)$</a>特斯拉目前为历史最高点，潜在突破位置，两种可能一是回调，二是突破新高千亿市值(个人认为千亿可期)，无论从哪里看特斯拉已经是成熟企业，值得千亿市值了。总的来说目前位置是高点，持有有风险也可能有收益。不能否认这个位置肯定有很多人会选择空。现在就看是空头获胜还是多头获胜。但是从技术上来看，今年6月份到目前12月份特斯拉股价的走势及波动判断，本次新高是一定会突破的。更重要的是我认为奈飞现在是行情启动点了，2020年2月份奈飞股价大概率400往上。也就是说我判断奈飞从现在持有到明年2月份大概率事件会有30%左右的收益。","text":"$特斯拉(TSLA)$重要提示$Netflix, Inc.(NFLX)$$苹果(AAPL)$$伯克希尔(BRK.A)$$阿里巴巴(BABA)$$微软(MSFT)$特斯拉目前为历史最高点，潜在突破位置，两种可能一是回调，二是突破新高千亿市值(个人认为千亿可期)，无论从哪里看特斯拉已经是成熟企业，值得千亿市值了。总的来说目前位置是高点，持有有风险也可能有收益。不能否认这个位置肯定有很多人会选择空。现在就看是空头获胜还是多头获胜。但是从技术上来看，今年6月份到目前12月份特斯拉股价的走势及波动判断，本次新高是一定会突破的。更重要的是我认为奈飞现在是行情启动点了，2020年2月份奈飞股价大概率400往上。也就是说我判断奈飞从现在持有到明年2月份大概率事件会有30%左右的收益。","images":[],"top":1,"highlighted":1,"essential":2,"paper":1,"likeSize":9,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/919869190","isVote":1,"tweetType":1,"viewCount":7004,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":371697,"gmtCreate":1546861887463,"gmtModify":1704785913609,"author":{"id":"3479576576056160","authorId":"3479576576056160","name":"东东南亚","avatar":"https://static.tigerbbs.com/d8c94e66f07db4943f9b584d30f6937f","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3479576576056160","authorIdStr":"3479576576056160"},"themes":[],"htmlText":"$特斯拉(TSLA)$$微软(MSFT)$ $Facebook(FB)$ $百度(BIDU)$ $阿里巴巴(BABA)$ $京东(JD)$ $苹果(AAPL)$ $AMD(AMD)$ 既然这么多朋友关注了我，我就对今晚特斯拉的走势做一个大胆的预测吧，今晚开盘322美元，然后走高到324，回调318左右，最后上涨到328，尾盘回调到325。","listText":"$特斯拉(TSLA)$$微软(MSFT)$ $Facebook(FB)$ $百度(BIDU)$ $阿里巴巴(BABA)$ $京东(JD)$ $苹果(AAPL)$ $AMD(AMD)$ 既然这么多朋友关注了我，我就对今晚特斯拉的走势做一个大胆的预测吧，今晚开盘322美元，然后走高到324，回调318左右，最后上涨到328，尾盘回调到325。","text":"$特斯拉(TSLA)$$微软(MSFT)$ $Facebook(FB)$ $百度(BIDU)$ $阿里巴巴(BABA)$ $京东(JD)$ $苹果(AAPL)$ $AMD(AMD)$ 既然这么多朋友关注了我，我就对今晚特斯拉的走势做一个大胆的预测吧，今晚开盘322美元，然后走高到324，回调318左右，最后上涨到328，尾盘回调到325。","images":[],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":11,"commentSize":10,"repostSize":0,"link":"https://laohu8.com/post/371697","isVote":1,"tweetType":1,"viewCount":4519,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"20727972514030","authorId":"20727972514030","name":"Tony特别帅","avatar":"https://static.tigerbbs.com/61f671464b0bc8103579e8d0e2197c48","crmLevel":1,"crmLevelSwitch":0,"idStr":"20727972514030","authorIdStr":"20727972514030"},"content":"nb啊@Skysjjs","text":"nb啊@Skysjjs","html":"nb啊@Skysjjs"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":907521436,"gmtCreate":1561976388025,"gmtModify":1704702837912,"author":{"id":"3479576576056160","authorId":"3479576576056160","name":"东东南亚","avatar":"https://static.tigerbbs.com/d8c94e66f07db4943f9b584d30f6937f","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3479576576056160","authorIdStr":"3479576576056160"},"themes":[],"htmlText":"$特斯拉(TSLA)$ 230以下今晚买多少都赚钱！千万别错过这波，马上就出Q2创纪录后边最少还有8个点的涨幅，拿稳了最高可能触及280这波","listText":"$特斯拉(TSLA)$ 230以下今晚买多少都赚钱！千万别错过这波，马上就出Q2创纪录后边最少还有8个点的涨幅，拿稳了最高可能触及280这波","text":"$特斯拉(TSLA)$ 230以下今晚买多少都赚钱！千万别错过这波，马上就出Q2创纪录后边最少还有8个点的涨幅，拿稳了最高可能触及280这波","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/907521436","isVote":1,"tweetType":1,"viewCount":3558,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":430149,"gmtCreate":1552657604724,"gmtModify":1704793152884,"author":{"id":"3479576576056160","authorId":"3479576576056160","name":"东东南亚","avatar":"https://static.tigerbbs.com/d8c94e66f07db4943f9b584d30f6937f","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3479576576056160","authorIdStr":"3479576576056160"},"themes":[],"htmlText":"$特斯拉(TSLA)$ 我还就真杠上了，打死我也不卖，有种你就跌吧","listText":"$特斯拉(TSLA)$ 我还就真杠上了，打死我也不卖，有种你就跌吧","text":"$特斯拉(TSLA)$ 我还就真杠上了，打死我也不卖，有种你就跌吧","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":6,"repostSize":0,"link":"https://laohu8.com/post/430149","isVote":1,"tweetType":1,"viewCount":1912,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"165243741689016","authorId":"165243741689016","name":"悠悠de梦","avatar":"https://static.tigerbbs.com/176f3d39a7fd793fe3725af1abc307ff","crmLevel":8,"crmLevelSwitch":1,"idStr":"165243741689016","authorIdStr":"165243741689016"},"content":"我昨天跟你一样，最高点上车的，麻痹","text":"我昨天跟你一样，最高点上车的，麻痹","html":"我昨天跟你一样，最高点上车的，麻痹"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":358742,"gmtCreate":1545169675840,"gmtModify":1704784319976,"author":{"id":"3479576576056160","authorId":"3479576576056160","name":"东东南亚","avatar":"https://static.tigerbbs.com/d8c94e66f07db4943f9b584d30f6937f","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3479576576056160","authorIdStr":"3479576576056160"},"themes":[],"htmlText":"$特斯拉(TSLA)$ 关于这几天特斯拉下跌的一点看法，顺势而为，我在13号发帖的时候已经逢高卖出空仓了，13号我就精准的预测到特斯拉未来几天的走势。","listText":"$特斯拉(TSLA)$ 关于这几天特斯拉下跌的一点看法，顺势而为，我在13号发帖的时候已经逢高卖出空仓了，13号我就精准的预测到特斯拉未来几天的走势。","text":"$特斯拉(TSLA)$ 关于这几天特斯拉下跌的一点看法，顺势而为，我在13号发帖的时候已经逢高卖出空仓了，13号我就精准的预测到特斯拉未来几天的走势。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":5,"repostSize":0,"link":"https://laohu8.com/post/358742","isVote":1,"tweetType":1,"viewCount":604,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3482560632197879","authorId":"3482560632197879","name":"眼镜飞侠","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"idStr":"3482560632197879","authorIdStr":"3482560632197879"},"content":"今天涨还是跌","text":"今天涨还是跌","html":"今天涨还是跌"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":337553,"gmtCreate":1542820186744,"gmtModify":1704781669942,"author":{"id":"3479576576056160","authorId":"3479576576056160","name":"东东南亚","avatar":"https://static.tigerbbs.com/d8c94e66f07db4943f9b584d30f6937f","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3479576576056160","authorIdStr":"3479576576056160"},"themes":[],"htmlText":"$AMD(AMD)$ 这个股开盘有追高的，不要着急，明天可能有机会出来","listText":"$AMD(AMD)$ 这个股开盘有追高的，不要着急，明天可能有机会出来","text":"$AMD(AMD)$ 这个股开盘有追高的，不要着急，明天可能有机会出来","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":6,"repostSize":0,"link":"https://laohu8.com/post/337553","isVote":1,"tweetType":1,"viewCount":2275,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3458243023492441","authorId":"3458243023492441","name":"yyyyc","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"idStr":"3458243023492441","authorIdStr":"3458243023492441"},"content":"明天休市","text":"明天休市","html":"明天休市"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":329904,"gmtCreate":1542131078942,"gmtModify":1704780703363,"author":{"id":"3479576576056160","authorId":"3479576576056160","name":"东东南亚","avatar":"https://static.tigerbbs.com/d8c94e66f07db4943f9b584d30f6937f","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3479576576056160","authorIdStr":"3479576576056160"},"themes":[],"htmlText":"$AMD(AMD)$ 这股均线全破，整体走势在下降通道，做多的要慎重！","listText":"$AMD(AMD)$ 这股均线全破，整体走势在下降通道，做多的要慎重！","text":"$AMD(AMD)$ 这股均线全破，整体走势在下降通道，做多的要慎重！","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":6,"repostSize":0,"link":"https://laohu8.com/post/329904","isVote":1,"tweetType":1,"viewCount":2287,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3502966070190695","authorId":"3502966070190695","name":"偏见","avatar":"https://static.tigerbbs.com/e6ee6fa59cb631272d055e447b77f14c","crmLevel":2,"crmLevelSwitch":0,"idStr":"3502966070190695","authorIdStr":"3502966070190695"},"content":"今天做空，小赌一下","text":"今天做空，小赌一下","html":"今天做空，小赌一下"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":381426,"gmtCreate":1547731833321,"gmtModify":1704787118192,"author":{"id":"3479576576056160","authorId":"3479576576056160","name":"东东南亚","avatar":"https://static.tigerbbs.com/d8c94e66f07db4943f9b584d30f6937f","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3479576576056160","authorIdStr":"3479576576056160"},"themes":[],"htmlText":"$Tilray Inc.(TLRY)$ 这个股票是不是随便一发力就上一百了","listText":"$Tilray Inc.(TLRY)$ 这个股票是不是随便一发力就上一百了","text":"$Tilray Inc.(TLRY)$ 这个股票是不是随便一发力就上一百了","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":5,"repostSize":0,"link":"https://laohu8.com/post/381426","isVote":1,"tweetType":1,"viewCount":1105,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3480491487515598","authorId":"3480491487515598","name":"建松","avatar":"https://static.tigerbbs.com/a35c3871b34f993c230362edfd34a11e","crmLevel":2,"crmLevelSwitch":0,"idStr":"3480491487515598","authorIdStr":"3480491487515598"},"content":"这时候说这话不靠谱","text":"这时候说这话不靠谱","html":"这时候说这话不靠谱"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":807469846,"gmtCreate":1628050746185,"gmtModify":1628050746185,"author":{"id":"3479576576056160","authorId":"3479576576056160","name":"东东南亚","avatar":"https://static.tigerbbs.com/d8c94e66f07db4943f9b584d30f6937f","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3479576576056160","authorIdStr":"3479576576056160"},"themes":[],"htmlText":"一切看成果，没有成果的事情都是耍流氓。","listText":"一切看成果，没有成果的事情都是耍流氓。","text":"一切看成果，没有成果的事情都是耍流氓。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/807469846","repostId":"1124757232","repostType":2,"repost":{"id":"1124757232","pubTimestamp":1628045612,"share":"https://www.laohu8.com/m/news/1124757232?lang=&edition=full","pubTime":"2021-08-04 10:53","market":"us","language":"en","title":"3 COVID Stocks That Could Soar Higher","url":"https://stock-news.laohu8.com/highlight/detail?id=1124757232","media":"The Motley Fool","summary":"Here's why Pfizer, Inari Medical, and Novavax shares might be more valuable in 2021.\nKey Points\n\nPfi","content":"<p><b><i>Here's why Pfizer, Inari Medical, and Novavax shares might be more valuable in 2021.</i></b></p>\n<p><b>Key Points</b></p>\n<ul>\n <li>Pfizer might surprise to the upside.</li>\n <li>Inari Medical is growing like gangbusters.</li>\n <li>Novavax's vaccine might be an important booster shot as the COVID-19 virus mutates.</li>\n</ul>\n<p>COVID-19 and the international lockdown crashed the world economy in 2020. Many people have already been vaccinated and are looking forward to normalization. But COVID is mutating, and the new delta variant might toss a wrench into the world's reopening. How might investors protect themselves?</p>\n<p>A panel of Motley Fool contributors offers three ideas for healthcare stocks that will zoom higher in 2021, even if COVID takes a turn for the worse. Read more to see why you might want to buy shares of&nbsp;<b><a href=\"https://laohu8.com/S/PFE\">Pfizer</a></b>,&nbsp;<b><a href=\"https://laohu8.com/S/NARI\">Inari Medical, Inc.</a></b>, and&nbsp;<b><a href=\"https://laohu8.com/S/NVAX\">Novavax</a></b>.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/f3ed6a343e35e121aafbaa2b30134955\" tg-width=\"2000\" tg-height=\"1333\" width=\"100%\" height=\"auto\"><span>IMAGE SOURCE: GETTY IMAGES.</span></p>\n<h3><b>Pfizer: More room to run</b></h3>\n<p><b>George Budwell</b>&nbsp;<b>(Pfizer):</b>&nbsp;American pharma titan Pfizer might not sound like a sexy pick among the present cohort of COVID vaccine players. Wall Street's current consensus has Comirnaty, the drugmaker's vaccine -- produced in partnership with&nbsp;<a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a>&nbsp;-- losing steam from a sales perspective starting in 2022.</p>\n<p>Because of the delta variant, however, Comirnaty's commercial life could turn out to be much longer than originally expected. And while the emergence of the highly transmissible variant is obviously terrible news for society at large, Pfizer and its shareholders are probably going to benefit from this unfortunate development.</p>\n<p>There are two clear reasons to think that Pfizer's stock could move higher on the delta issue. First and foremost, the company&nbsp;announced&nbsp;that an Emergency Use Authorization submission for a booster third shot might happen as soon as this month. Second, Pfizer plans to start clinical trials for a delta-specific version of the vaccine this month.</p>\n<p>Although the Food and Drug Administration and the Centers for Disease Control and Prevention have both recently downplayed the need for booster shots, Pfizer has already put forth a compelling case for a third jab in response to the rampant spread of the delta variant and the waning efficacy of Comirnaty 6 to 12 months following full vaccination.</p>\n<p>The big picture for investors is that Pfizer's 2022 revenue might jump by as much as 9.7% compared to 2021 -- that is, if a booster shot is indeed approved and the company also successfully develops a delta-specific vaccine. By contrast, Wall Street currently has the drugmaker's top line falling by 14.8% next year relative to 2021.</p>\n<p>Where is Pfizer's stock possibly headed? If all the pieces fall into place on the vaccine front, shares ought to command a $50 handle, from a conservative standpoint. That's roughly a 17% upswing from where the drugmaker's shares presently stand, and that's not even accounting for the company's attractive 3.64% dividend yield at current levels. Put simply, Pfizer's stock would only be trading at approximately 3.5 times 2022 sales if this scenario pans out, which is a rather modest valuation for a&nbsp;dividend-paying&nbsp;big pharma stock.</p>\n<h3><b>Inari Medical: Skyrocketing Sales</b></h3>\n<p><b>Patrick Bafuma</b>&nbsp;<b>(Inari Medical):</b>&nbsp;If you are looking for a stock with staying power after tailwinds from the pandemic subside, look to Inari Medical. There were 108,000 new COVID cases on July 27, 2021 -- the most since February 5, 2021, according to&nbsp;<i>The New York Times</i>&nbsp;-- and that number was up over eight times the seven-day average at the start of July. To make things even worse, COVID not only causes difficulty breathing but also more than triples a patient's risk of disabling and potentially life-threatening blood clots. And we're still not sure if being vaccinated fully mitigates the risk of blood clots when a patient has an asymptomatic or a mild COVID infection.</p>\n<p>This seems like a good setup for a commercial-stage med-tech company that has developed minimally invasive products designed to remove large blood clots without the need for powerful clot-busting drugs. Through the use of its ClotTriever and FlowTriever devices, Inari has treated over 25,000 patients so far. Clinicians performed approximately 5,500 procedures with the company's devices in the first quarter of 2021,&nbsp;up 130% from the same quarter last year&nbsp;and about 20% higher than the fourth quarter of 2020. With about 12% of admitted COVID patients developing blood clots, and about 35,000 COVID hospitalizations in the U.S. (and rising) as of July 27, according to<i>The Times</i>, Inari is likely to see an uptick in eligible cases.</p>\n<p>Not to mention the company's results thus far for blood clots in the lung are spectacular:</p>\n<ul>\n <li>With the historic 30-day mortality rate of intermediate and high-risk blood clots in the lungs at 9.7%, Inari's 0.4% 30-day mortality rate is impressive.</li>\n <li>There's a decreased 30-day readmission rate of 6.7% versus 24.4% with the usual care.</li>\n <li>Major adverse events within 48 hours occur at only a 1.3% rate.</li>\n <li>No ICU stays are required after the procedure.</li>\n</ul>\n<p>Add it all up, and Inari's retrieval device seems like an obvious choice.</p>\n<p>The company grew first-quarter revenue at 113% year over year, and&nbsp;18% sequentially, and had gross margins of 91.9% for the first quarter of 2021. So Inari's price-to-sales ratio of 18 makes it a growth stock on sale.</p>\n<p>Inari has&nbsp;less than 5% penetrationin the $3.8 billion U.S. market, and there's also lots of room to grow in Europe, where it launched earlier this year. That means there are plenty of opportunities for this $4.5-billion market cap company. While COVID has affected many elective and semi-elective procedures, it has clearly not slowed Inari, and it could even accelerate its uptake.</p>\n<h3><b>Novavax: How high can it go?</b></h3>\n<p><b>Taylor Carmichael</b>&nbsp;<b>(Novavax):</b>&nbsp;The vaccine&nbsp;biotech&nbsp;Novavax had an amazing 2020, with its share price running up&nbsp;2,700%&nbsp;on optimism for its COVID vaccine. While the company has yet to file for an Emergency Use Authorization, it expects to do so in this quarter. So far in 2021, the stock is up 60%.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/0e7829d99a76c48579ba01c6e55fe14f\" tg-width=\"720\" tg-height=\"449\" width=\"100%\" height=\"auto\"><span>NVAX DATA BY YCHARTS.</span></p>\n<p>Positive phase 3 data for the COVID-19 vaccine sent the stock soaring early in the year, but the share price has come back down to earth as the company has suffered delays getting its vaccine to market. First there was a shortage of raw materials necessary to make the vaccine. Now the company has to prove that its various contract manufacturing facilities will keep the vaccine quality consistent across all the sites.</p>\n<p>Despite these delays, long-term investors have reasons to be bullish. Manufacturing is scaling up, with production rates expected to hit 100 million doses a month by the end of the third quarter, and 150 million doses a month by December. While many people in the U.S. have already been vaccinated, the opportunity in the rest of the world is sizable. Novavax has pre-sold 1.1 billion doses to COVAX (an international vaccine consortium), and has contracted to supply hundreds of millions of doses around the world.</p>\n<p>In the U.S., the Novavax vaccine might primarily be used as a&nbsp;booster shot&nbsp;for people who have already been vaccinated. \"They may be really the right ones for boosters,\" Dr. Luciana Borio, the acting chief scientist at the F.D.A. from 2015 to 2017, told&nbsp;<i>The New York Times</i>.</p>\n<p>Down the road, Novavax plans on combining its COVID vaccine with its flu vaccine, making aone-shot regimen. While COVID does not mutate as quickly as the flu, we've seen several mutating strains over the last year. It's likely that we will need to vaccinate more than once in the years ahead.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 COVID Stocks That Could Soar Higher</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 COVID Stocks That Could Soar Higher\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-04 10:53 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/08/03/3-covid-stocks-that-will-soar-higher/><strong>The Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Here's why Pfizer, Inari Medical, and Novavax shares might be more valuable in 2021.\nKey Points\n\nPfizer might surprise to the upside.\nInari Medical is growing like gangbusters.\nNovavax's vaccine might...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/03/3-covid-stocks-that-will-soar-higher/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药","NARI":"Inari Medical, Inc.","PFE":"辉瑞"},"source_url":"https://www.fool.com/investing/2021/08/03/3-covid-stocks-that-will-soar-higher/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1124757232","content_text":"Here's why Pfizer, Inari Medical, and Novavax shares might be more valuable in 2021.\nKey Points\n\nPfizer might surprise to the upside.\nInari Medical is growing like gangbusters.\nNovavax's vaccine might be an important booster shot as the COVID-19 virus mutates.\n\nCOVID-19 and the international lockdown crashed the world economy in 2020. Many people have already been vaccinated and are looking forward to normalization. But COVID is mutating, and the new delta variant might toss a wrench into the world's reopening. How might investors protect themselves?\nA panel of Motley Fool contributors offers three ideas for healthcare stocks that will zoom higher in 2021, even if COVID takes a turn for the worse. Read more to see why you might want to buy shares of Pfizer, Inari Medical, Inc., and Novavax.\nIMAGE SOURCE: GETTY IMAGES.\nPfizer: More room to run\nGeorge Budwell (Pfizer): American pharma titan Pfizer might not sound like a sexy pick among the present cohort of COVID vaccine players. Wall Street's current consensus has Comirnaty, the drugmaker's vaccine -- produced in partnership with BioNTech SE -- losing steam from a sales perspective starting in 2022.\nBecause of the delta variant, however, Comirnaty's commercial life could turn out to be much longer than originally expected. And while the emergence of the highly transmissible variant is obviously terrible news for society at large, Pfizer and its shareholders are probably going to benefit from this unfortunate development.\nThere are two clear reasons to think that Pfizer's stock could move higher on the delta issue. First and foremost, the company announced that an Emergency Use Authorization submission for a booster third shot might happen as soon as this month. Second, Pfizer plans to start clinical trials for a delta-specific version of the vaccine this month.\nAlthough the Food and Drug Administration and the Centers for Disease Control and Prevention have both recently downplayed the need for booster shots, Pfizer has already put forth a compelling case for a third jab in response to the rampant spread of the delta variant and the waning efficacy of Comirnaty 6 to 12 months following full vaccination.\nThe big picture for investors is that Pfizer's 2022 revenue might jump by as much as 9.7% compared to 2021 -- that is, if a booster shot is indeed approved and the company also successfully develops a delta-specific vaccine. By contrast, Wall Street currently has the drugmaker's top line falling by 14.8% next year relative to 2021.\nWhere is Pfizer's stock possibly headed? If all the pieces fall into place on the vaccine front, shares ought to command a $50 handle, from a conservative standpoint. That's roughly a 17% upswing from where the drugmaker's shares presently stand, and that's not even accounting for the company's attractive 3.64% dividend yield at current levels. Put simply, Pfizer's stock would only be trading at approximately 3.5 times 2022 sales if this scenario pans out, which is a rather modest valuation for a dividend-paying big pharma stock.\nInari Medical: Skyrocketing Sales\nPatrick Bafuma (Inari Medical): If you are looking for a stock with staying power after tailwinds from the pandemic subside, look to Inari Medical. There were 108,000 new COVID cases on July 27, 2021 -- the most since February 5, 2021, according to The New York Times -- and that number was up over eight times the seven-day average at the start of July. To make things even worse, COVID not only causes difficulty breathing but also more than triples a patient's risk of disabling and potentially life-threatening blood clots. And we're still not sure if being vaccinated fully mitigates the risk of blood clots when a patient has an asymptomatic or a mild COVID infection.\nThis seems like a good setup for a commercial-stage med-tech company that has developed minimally invasive products designed to remove large blood clots without the need for powerful clot-busting drugs. Through the use of its ClotTriever and FlowTriever devices, Inari has treated over 25,000 patients so far. Clinicians performed approximately 5,500 procedures with the company's devices in the first quarter of 2021, up 130% from the same quarter last year and about 20% higher than the fourth quarter of 2020. With about 12% of admitted COVID patients developing blood clots, and about 35,000 COVID hospitalizations in the U.S. (and rising) as of July 27, according toThe Times, Inari is likely to see an uptick in eligible cases.\nNot to mention the company's results thus far for blood clots in the lung are spectacular:\n\nWith the historic 30-day mortality rate of intermediate and high-risk blood clots in the lungs at 9.7%, Inari's 0.4% 30-day mortality rate is impressive.\nThere's a decreased 30-day readmission rate of 6.7% versus 24.4% with the usual care.\nMajor adverse events within 48 hours occur at only a 1.3% rate.\nNo ICU stays are required after the procedure.\n\nAdd it all up, and Inari's retrieval device seems like an obvious choice.\nThe company grew first-quarter revenue at 113% year over year, and 18% sequentially, and had gross margins of 91.9% for the first quarter of 2021. So Inari's price-to-sales ratio of 18 makes it a growth stock on sale.\nInari has less than 5% penetrationin the $3.8 billion U.S. market, and there's also lots of room to grow in Europe, where it launched earlier this year. That means there are plenty of opportunities for this $4.5-billion market cap company. While COVID has affected many elective and semi-elective procedures, it has clearly not slowed Inari, and it could even accelerate its uptake.\nNovavax: How high can it go?\nTaylor Carmichael (Novavax): The vaccine biotech Novavax had an amazing 2020, with its share price running up 2,700% on optimism for its COVID vaccine. While the company has yet to file for an Emergency Use Authorization, it expects to do so in this quarter. So far in 2021, the stock is up 60%.\nNVAX DATA BY YCHARTS.\nPositive phase 3 data for the COVID-19 vaccine sent the stock soaring early in the year, but the share price has come back down to earth as the company has suffered delays getting its vaccine to market. First there was a shortage of raw materials necessary to make the vaccine. Now the company has to prove that its various contract manufacturing facilities will keep the vaccine quality consistent across all the sites.\nDespite these delays, long-term investors have reasons to be bullish. Manufacturing is scaling up, with production rates expected to hit 100 million doses a month by the end of the third quarter, and 150 million doses a month by December. While many people in the U.S. have already been vaccinated, the opportunity in the rest of the world is sizable. Novavax has pre-sold 1.1 billion doses to COVAX (an international vaccine consortium), and has contracted to supply hundreds of millions of doses around the world.\nIn the U.S., the Novavax vaccine might primarily be used as a booster shot for people who have already been vaccinated. \"They may be really the right ones for boosters,\" Dr. Luciana Borio, the acting chief scientist at the F.D.A. from 2015 to 2017, told The New York Times.\nDown the road, Novavax plans on combining its COVID vaccine with its flu vaccine, making aone-shot regimen. While COVID does not mutate as quickly as the flu, we've seen several mutating strains over the last year. It's likely that we will need to vaccinate more than once in the years ahead.","news_type":1},"isVote":1,"tweetType":1,"viewCount":2030,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":349243,"gmtCreate":1544182519792,"gmtModify":1704783149832,"author":{"id":"3479576576056160","authorId":"3479576576056160","name":"东东南亚","avatar":"https://static.tigerbbs.com/d8c94e66f07db4943f9b584d30f6937f","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3479576576056160","authorIdStr":"3479576576056160"},"themes":[],"htmlText":"$特斯拉(TSLA)$ 分析一下特斯拉今天盘前异动，我个人认为盘前是诱多，开盘应该是360左右，这样对360左右会形成一部分支撑，至于为什么要在360左右形成支撑位，我觉得新闻已经告诉我们答案了，明年三月份。","listText":"$特斯拉(TSLA)$ 分析一下特斯拉今天盘前异动，我个人认为盘前是诱多，开盘应该是360左右，这样对360左右会形成一部分支撑，至于为什么要在360左右形成支撑位，我觉得新闻已经告诉我们答案了，明年三月份。","text":"$特斯拉(TSLA)$ 分析一下特斯拉今天盘前异动，我个人认为盘前是诱多，开盘应该是360左右，这样对360左右会形成一部分支撑，至于为什么要在360左右形成支撑位，我觉得新闻已经告诉我们答案了，明年三月份。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/349243","isVote":1,"tweetType":1,"viewCount":776,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3479576576056160","authorId":"3479576576056160","name":"东东南亚","avatar":"https://static.tigerbbs.com/d8c94e66f07db4943f9b584d30f6937f","crmLevel":4,"crmLevelSwitch":0,"idStr":"3479576576056160","authorIdStr":"3479576576056160"},"content":"近期布局在360形成支撑，等毛衣战关于汽车关税的公布，又会形成一波行情，最终稳定在400左右，明年三月份无压力！","text":"近期布局在360形成支撑，等毛衣战关于汽车关税的公布，又会形成一波行情，最终稳定在400左右，明年三月份无压力！","html":"近期布局在360形成支撑，等毛衣战关于汽车关税的公布，又会形成一波行情，最终稳定在400左右，明年三月份无压力！"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":371126,"gmtCreate":1546657124265,"gmtModify":1704785836934,"author":{"id":"3479576576056160","authorId":"3479576576056160","name":"东东南亚","avatar":"https://static.tigerbbs.com/d8c94e66f07db4943f9b584d30f6937f","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3479576576056160","authorIdStr":"3479576576056160"},"themes":[],"htmlText":"$特斯拉(TSLA)$ $苹果(AAPL)$ $AMD(AMD)$ $拼多多(PDD)$ $京东(JD)$ $PayPal(PYPL)$ $阿里巴巴(BABA)$ $百度(BIDU)$ $微软(MSFT)$ $Facebook(FB)$ 对于炒股亏损的一点建议，强烈推荐大家看看我发的2018年投资大复盘那个加精的帖子，里面讲的很明确，我相信能够帮助你重新树立一些炒股观念。","listText":"$特斯拉(TSLA)$ $苹果(AAPL)$ $AMD(AMD)$ $拼多多(PDD)$ $京东(JD)$ $PayPal(PYPL)$ $阿里巴巴(BABA)$ $百度(BIDU)$ $微软(MSFT)$ $Facebook(FB)$ 对于炒股亏损的一点建议，强烈推荐大家看看我发的2018年投资大复盘那个加精的帖子，里面讲的很明确，我相信能够帮助你重新树立一些炒股观念。","text":"$特斯拉(TSLA)$ $苹果(AAPL)$ $AMD(AMD)$ $拼多多(PDD)$ $京东(JD)$ $PayPal(PYPL)$ $阿里巴巴(BABA)$ $百度(BIDU)$ $微软(MSFT)$ $Facebook(FB)$ 对于炒股亏损的一点建议，强烈推荐大家看看我发的2018年投资大复盘那个加精的帖子，里面讲的很明确，我相信能够帮助你重新树立一些炒股观念。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/371126","isVote":1,"tweetType":1,"viewCount":1564,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":334370,"gmtCreate":1542637133620,"gmtModify":1704781265800,"author":{"id":"3479576576056160","authorId":"3479576576056160","name":"东东南亚","avatar":"https://static.tigerbbs.com/d8c94e66f07db4943f9b584d30f6937f","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3479576576056160","authorIdStr":"3479576576056160"},"themes":[],"htmlText":"$AMD(AMD)$ 【美国商务部提议技术出口管制方案】11月19日，美国商务部工业与安全局提出了一份针对关键技术和相关产品的出口管制框架方案，并将面向公众进行为期一个月的意见征询。该文件列出了14个考虑进行管制的领域，包括生物技术、人工智能（AI）、数据分析、量子计算、机器人、脑机接口等在内的前沿技术。（财经）","listText":"$AMD(AMD)$ 【美国商务部提议技术出口管制方案】11月19日，美国商务部工业与安全局提出了一份针对关键技术和相关产品的出口管制框架方案，并将面向公众进行为期一个月的意见征询。该文件列出了14个考虑进行管制的领域，包括生物技术、人工智能（AI）、数据分析、量子计算、机器人、脑机接口等在内的前沿技术。（财经）","text":"$AMD(AMD)$ 【美国商务部提议技术出口管制方案】11月19日，美国商务部工业与安全局提出了一份针对关键技术和相关产品的出口管制框架方案，并将面向公众进行为期一个月的意见征询。该文件列出了14个考虑进行管制的领域，包括生物技术、人工智能（AI）、数据分析、量子计算、机器人、脑机接口等在内的前沿技术。（财经）","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/334370","isVote":1,"tweetType":1,"viewCount":2869,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":332514,"gmtCreate":1542319997536,"gmtModify":1704781031638,"author":{"id":"3479576576056160","authorId":"3479576576056160","name":"东东南亚","avatar":"https://static.tigerbbs.com/d8c94e66f07db4943f9b584d30f6937f","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3479576576056160","authorIdStr":"3479576576056160"},"themes":[],"htmlText":"$AMD(AMD)$ 开盘最起码跌10点","listText":"$AMD(AMD)$ 开盘最起码跌10点","text":"$AMD(AMD)$ 开盘最起码跌10点","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/332514","isVote":1,"tweetType":1,"viewCount":1888,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":327618,"gmtCreate":1541783376515,"gmtModify":1704780404947,"author":{"id":"3479576576056160","authorId":"3479576576056160","name":"东东南亚","avatar":"https://static.tigerbbs.com/d8c94e66f07db4943f9b584d30f6937f","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3479576576056160","authorIdStr":"3479576576056160"},"themes":[],"htmlText":"$AMD(AMD)$ 什么利好都没有就逆着大盘走，牛啊","listText":"$AMD(AMD)$ 什么利好都没有就逆着大盘走，牛啊","text":"$AMD(AMD)$ 什么利好都没有就逆着大盘走，牛啊","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/327618","isVote":1,"tweetType":1,"viewCount":392,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3460069418786589","authorId":"3460069418786589","name":"凯凯和哼哼","avatar":"https://static.tigerbbs.com/130c6b9ca6a99fe503d18f20735f62a1","crmLevel":2,"crmLevelSwitch":0,"idStr":"3460069418786589","authorIdStr":"3460069418786589"},"content":"感觉啊，也就这个股热门股，感觉被低估，并且有很大潜力，越是熊市，这种潜质越被人放大。 前几天的亚马逊宣布使用amd的产品，再加上7nm的发布，都是利好","text":"感觉啊，也就这个股热门股，感觉被低估，并且有很大潜力，越是熊市，这种潜质越被人放大。 前几天的亚马逊宣布使用amd的产品，再加上7nm的发布，都是利好","html":"感觉啊，也就这个股热门股，感觉被低估，并且有很大潜力，越是熊市，这种潜质越被人放大。 前几天的亚马逊宣布使用amd的产品，再加上7nm的发布，都是利好"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":934716059,"gmtCreate":1574448838071,"gmtModify":1704728065552,"author":{"id":"3479576576056160","authorId":"3479576576056160","name":"东东南亚","avatar":"https://static.tigerbbs.com/d8c94e66f07db4943f9b584d30f6937f","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3479576576056160","authorIdStr":"3479576576056160"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TSLA\">$特斯拉(TSLA)$</a>发点看法，不知道对不对，第四季度10万多的销售量能达到吗？国内特斯拉听说明年一月份才能交付，是不是今年第四季度表示并不能帮上什么忙吧？那么全面的销售目标我觉得有很大风险是达不到的啊。还是觉得全年目标有点风险。","listText":"<a href=\"https://laohu8.com/S/TSLA\">$特斯拉(TSLA)$</a>发点看法，不知道对不对，第四季度10万多的销售量能达到吗？国内特斯拉听说明年一月份才能交付，是不是今年第四季度表示并不能帮上什么忙吧？那么全面的销售目标我觉得有很大风险是达不到的啊。还是觉得全年目标有点风险。","text":"$特斯拉(TSLA)$发点看法，不知道对不对，第四季度10万多的销售量能达到吗？国内特斯拉听说明年一月份才能交付，是不是今年第四季度表示并不能帮上什么忙吧？那么全面的销售目标我觉得有很大风险是达不到的啊。还是觉得全年目标有点风险。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/934716059","isVote":1,"tweetType":1,"viewCount":3917,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":450109,"gmtCreate":1553896869158,"gmtModify":1704795761339,"author":{"id":"3479576576056160","authorId":"3479576576056160","name":"东东南亚","avatar":"https://static.tigerbbs.com/d8c94e66f07db4943f9b584d30f6937f","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3479576576056160","authorIdStr":"3479576576056160"},"themes":[],"htmlText":"$特斯拉(TSLA)$ 特斯拉国内大家可能都在等国产，所以国内销售现在应该不会太多","listText":"$特斯拉(TSLA)$ 特斯拉国内大家可能都在等国产，所以国内销售现在应该不会太多","text":"$特斯拉(TSLA)$ 特斯拉国内大家可能都在等国产，所以国内销售现在应该不会太多","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/450109","isVote":1,"tweetType":1,"viewCount":2468,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":360222,"gmtCreate":1545297200104,"gmtModify":1704784510210,"author":{"id":"3479576576056160","authorId":"3479576576056160","name":"东东南亚","avatar":"https://static.tigerbbs.com/d8c94e66f07db4943f9b584d30f6937f","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3479576576056160","authorIdStr":"3479576576056160"},"themes":[],"htmlText":"$特斯拉(TSLA)$ 上周五，美国国内税务局表示，从2019年1月1日开始，特斯拉买家的税收抵免额将降至3750美元，到2019年底全部取消。要抓重点！近期市场走向参考","listText":"$特斯拉(TSLA)$ 上周五，美国国内税务局表示，从2019年1月1日开始，特斯拉买家的税收抵免额将降至3750美元，到2019年底全部取消。要抓重点！近期市场走向参考","text":"$特斯拉(TSLA)$ 上周五，美国国内税务局表示，从2019年1月1日开始，特斯拉买家的税收抵免额将降至3750美元，到2019年底全部取消。要抓重点！近期市场走向参考","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/360222","isVote":1,"tweetType":1,"viewCount":637,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}